, Pingré, Alexandre‐Guy

A. Guy, L. Deloison, V. Gourdou-latyszenok, S. Favre, S. Colomer et al., Étude des propriétés prothrombotiques des polynucléaires neutrophiles dans les néoplasies myéloprolifératives, JMV-Journal de Médecine Vasculaire, vol.44, issue.2, pp.135-136, 2019.

, Le Clerc, Nicolas, Nicolas Le Lay, 2011.

C. A. Claire-adam, C. A. Claire-adam, C. A. Claire-adam, C. A. Claire-adam, C. A. Claire-adam et al., DominoesStars.com-play Dominos for Free - Tournaments, Claire Peghaire, 2011.

H. Kilani, A. Al-za?abi, A. Kilani, and L. Kilani, Fetal-Neonatal Lifestyle Basis of the Adult Metabolic Syndrome Patients, Cardiorespiratory Fitness, 2020.

P. Dias, Vieira, Jacinto, Juliana Vieira Dias, 2003.

, Thorel, Marie Cécile or Cécile Marie, 2011.

M. , Fauville, Marie Ange, 2011.

M. Flonneau, Cécile Katz, Territoire d?usines. L?architecture industrielle en Seine-Saint-Denis, Paris, Créaphis, 2003,215 p., Histoire urbaine, vol.n° 9, issue.1, p.160, 2004.

J. Villeval, Herman, Jean Luc, 2011.

A. A. Bekkat, Kateb, Yacine, Yacine Boulaftali, vol.2, 2005.

M. Guillin and M. Jandrot-perrus, 2.W14.1 Thrombin interactions with vascular and non vascular cells, Atherosclerosis, vol.134, issue.1-2, p.111, 1997.
URL : https://hal.archives-ouvertes.fr/inserm-00619240

, Thierry, Thierry, Thierry Couffinhal 1, 2011.

T. C. Tyler-chloe, T. C. Tyler-chloe, T. C. Tyler-chloe, T. C. Tyler-chloe, T. C. Tyler-chloe et al., Training school Job Placement Assistance Career Training Academy, Chloe James, vol.1, issue.6, 2011.

. Univ and . Bordeaux, Inserm, UMR1034, Biology of Cardiovascular Diseases, F-33600

S. You and L. Chatenoud, The Concerted Action of Multiple Mechanisms to Induce and Sustain Transplant Tolerance, OBM Transplantation, vol.2, issue.4, pp.1-1, 2018.

, Transforming property of an HBV-cyclin a fusion protein identified in a human hepatocellular carcinoma INSERM U370, Institut Necker, Paris, France. *CNRS UA 1158, Institut Gustave Roussy, Villejuif, France, Hepatology, vol.22, issue.4, p.A157, 1995.

S. Yamashita, A. J. Shah, S. Mahida, J. Sellal, B. Berte et al., Body Surface Mapping to Guide Atrial Fibrillation Ablation, Arrhythmia & Electrophysiology Review, vol.4, issue.3, p.172, 2015.

D. A. Arber, A. Orazi, and R. Hasserjian, Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-2405., Blood, vol.128, issue.3, pp.462-463, 2016.

E. J. Baxter, L. M. Scott, P. J. Campbell, C. East, N. Fourouclas et al., Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders, The Lancet, vol.365, issue.9464, pp.1054-1061, 2005.

C. James, V. Ugo, J. Le-couédic, J. Staerk, F. Delhommeau et al., A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera, Nature, vol.434, issue.7037, pp.1144-1148, 2005.

R. Kralovics, F. Passamonti, A. S. Buser, S. Teo, R. Tiedt et al., A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders, New England Journal of Medicine, vol.352, issue.17, pp.1779-1790, 2005.

R. L. Levine, M. Wadleigh, and J. Cools, Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis, Cancer Cell, vol.7, issue.4, pp.387-397, 2005.

X. Lu, L. Huang, and H. F. Lodish, Dimerization by a Cytokine Receptor Is Necessary for Constitutive Activation of JAK2V617F, Journal of Biological Chemistry, vol.283, issue.9, pp.5258-5266, 2007.

M. A. Elliott and A. Tefferi, Pathogenesis and management of bleeding in essential thrombocythemia and polycythemia vera, Curr Hematol Rep, vol.3, issue.5, pp.344-351, 2004.

T. Barbui, G. Finazzi, and A. Falanga, Myeloproliferative neoplasms and thrombosis, Blood, vol.122, issue.13, pp.2176-2184, 2013.

A. Falanga, M. Marchetti, A. Vignoli, D. Balducci, and T. Barbui, Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera, Experimental Hematology, vol.33, issue.5, pp.523-530, 2005.

T. Barbui, A. Carobbio, A. Rambaldi, and G. Finazzi, Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?, Blood, vol.114, issue.4, pp.759-763, 2009.

R. Landolfi, L. Di-gennaro, T. Barbui, V. De-stefano, G. Finazzi et al., Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera, Blood, vol.109, issue.6, pp.2446-2452, 2006.

M. De-grandis, M. Cambot, M. Wautier, B. Cassinat, C. Chomienne et al., JAK2V617F activates Lu/BCAM-mediated red cell adhesion in polycythemia vera through an EpoR-independent Rap1/Akt pathway, Blood, vol.121, issue.4, pp.658-665, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00821109

V. Rosti, L. Villani, R. Riboni, V. Poletto, E. Bonetti et al., Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation, Blood, vol.121, issue.2, pp.360-368, 2013.

S. Sozer, M. I. Fiel, T. Schiano, M. Xu, J. Mascarenhas et al., The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome, Blood, vol.113, issue.21, pp.5246-5249, 2009.

L. Teofili, M. Martini, M. G. Iachininoto, S. Capodimonti, E. R. Nuzzolo et al., Endothelial progenitor cells are clonal and exhibit the JAK2V617F mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms, Blood, vol.117, issue.9, pp.2700-2707, 2011.

T. W. Wakefield, D. D. Myers, and P. K. Henke, Mechanisms of Venous Thrombosis and Resolution, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, issue.3, pp.387-391, 2008.

N. Kaneider, E. Förster, B. Mosheimer, D. Sturn, and C. Wiedermann, Syndecan-4-dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin, Thrombosis and Haemostasis, vol.90, issue.12, pp.1150-1157, 2003.

M. P. Burns and N. Depaola, Flow-conditioned HUVECs support clustered leukocyte adhesion by coexpressing ICAM-1 and E-selectin, American Journal of Physiology-Heart and Circulatory Physiology, vol.288, issue.1, pp.H194-H204, 2005.

K. Miszti-blasius, I. B. Debreceni, S. Felszeghy, B. Dezs?, and J. Kappelmayer, Lack of P-selectin glycoprotein ligand-1 protects mice from thrombosis after collagen/epinephrine challenge, Thrombosis Research, vol.127, issue.3, pp.228-234, 2011.

S. Séverin, M. Gratacap, N. Lenain, L. Alvarez, E. Hollande et al., Deficiency of Src homology 2 domain?containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth, Journal of Clinical Investigation, vol.117, issue.4, pp.944-952, 2007.

S. Hasan, C. Lacout, C. Marty, M. Cuingnet, E. Solary et al., JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFN?, Blood, vol.122, issue.8, pp.1464-1477, 2013.

S. Claxton, V. Kostourou, S. Jadeja, P. Chambon, K. Hodivala-dilke et al., Efficient, inducible Cre-recombinase activation in vascular endothelium, genesis, vol.46, issue.2, pp.74-80, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00282602

R. Thambyrajah, M. Mazan, R. Patel, V. Moignard, M. Stefanska et al., GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruitment of LSD1, Nature Cell Biology, vol.18, issue.1, pp.21-32, 2015.

L. Wang, R. Benedito, M. G. Bixel, D. Zeuschner, M. Stehling et al., Identification of a clonally expanding haematopoietic compartment in bone marrow, The EMBO Journal, vol.32, issue.2, pp.219-230, 2012.

A. K. Chauhan, J. Kisucka, A. Brill, M. T. Walsh, F. Scheiflinger et al., ADAMTS13: a new link between thrombosis and inflammation, Journal of Experimental Medicine, vol.205, issue.9, pp.2065-2074, 2008.

F. Wegmann, B. Petri, A. G. Khandoga, C. Moser, A. Khandoga et al., ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability, Journal of Experimental Medicine, vol.203, issue.7, pp.1671-1677, 2006.

T. Yago, H. Tsukamoto, Z. Liu, Y. Wang, L. F. Thompson et al., Multi-Inhibitory Effects of A2A Adenosine Receptor Signaling on Neutrophil Adhesion Under Flow, The Journal of Immunology, vol.195, issue.8, pp.3880-3889, 2015.

M. L. Von-bruhl, K. Stark, and A. Steinhart, Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo, J Exp Med, vol.209, issue.4, pp.819-835, 2012.

K. Ley, C. Laudanna, M. I. Cybulsky, and S. Nourshargh, Getting to the site of inflammation: the leukocyte adhesion cascade updated, Nature Reviews Immunology, vol.7, issue.9, pp.678-689, 2007.

C. B. Almeida, C. Scheiermann, J. Jang, C. Prophete, F. F. Costa et al., Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice, Blood, vol.120, issue.14, pp.2879-2888, 2012.

P. Andre, D. Hartwell, I. Hrachovinova, S. Saffaripour, and D. D. Wagner, Pro-coagulant state resulting from high levels of soluble P-selectin in blood, Proceedings of the National Academy of Sciences, vol.97, issue.25, pp.13835-13840, 2000.

E. Zetterberg, M. Verrucci, F. Martelli, M. Zingariello, L. Sancillo et al., Abnormal P-selectin localization during megakaryocyte development determines thrombosis in the gata1low model of myelofibrosis, Platelets, vol.25, issue.7, pp.539-547, 2013.

J. Etulain, K. Martinod, S. L. Wong, S. M. Cifuni, M. Schattner et al., P-selectin promotes neutrophil extracellular trap formation in mice, Blood, vol.126, issue.2, pp.242-246, 2015.

K. Martinod and D. D. Wagner, Thrombosis: tangled up in NETs, Blood, vol.123, issue.18, pp.2768-2776, 2014.

K. Kim, S. Kwon, J. Yun, H. Jeong, H. Kim et al., STAT3 activation in endothelial cells is important for tumor metastasis via increased cell adhesion molecule expression, Oncogene, vol.36, issue.39, pp.5445-5459, 2017.

R. Helman, W. D. Pereira, L. C. Marti, P. V. Campregher, R. D. Puga et al., Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm, British Journal of Haematology, vol.180, issue.3, pp.443-445, 2016.

G. Piaggio, V. Rosti, M. Corselli, F. Bertolotti, G. Bergamaschi et al., Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker, Blood, vol.114, issue.14, pp.3127-3130, 2009.

M. C. Yoder, L. E. Mead, D. Prater, T. R. Krier, K. N. Mroueh et al., Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals, Blood, vol.109, issue.5, pp.1801-1809, 2006.

S. Sozer, T. Ishii, M. I. Fiel, J. Wang, X. Wang et al., Human CD34+ cells are capable of generating normal and JAK2V617F positive endothelial like cells in vivo, Blood Cells, Molecules, and Diseases, vol.43, issue.3, pp.304-312, 2009.

V. P. Cokic, B. B. Beleslin--cokic, M. Tomic, S. S. Stojilkovic, C. T. Noguchi et al., Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells, Blood, vol.108, issue.1, pp.184-191, 2006.

V. P. Cokic, B. B. Beleslin-cokic, C. T. Noguchi, and A. N. Schechter, Hydroxyurea increases eNOS protein levels through inhibition of proteasome activity, Nitric Oxide, vol.16, issue.3, pp.371-378, 2007.

S. Charache, M. L. Terrin, and R. D. Moore, Literature Reviews: The Gene ? A Multipurpose Tool: Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle-Cell Anemia Charache S, Terrin ML, Moore RD, et al. N Engl J Med. 1995;332:1317-1322, Clinical Pediatrics, vol.34, issue.10, pp.568-568, 1995.

N. Gangat, A. P. Wolanskyj, R. F. Mcclure, C. Li, S. Schwager et al., Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients, Leukemia, vol.21, issue.2, pp.270-276, 2006.

G. Finazzi, V. Caruso, and R. Marchioli, Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study, Blood, vol.105, issue.7, pp.2664-2670, 2005.

A. Tefferi, E. Rumi, G. Finazzi, H. Gisslinger, A. M. Vannucchi et al., Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study, Leukemia, vol.27, issue.9, pp.1874-1881, 2013.

N. M. Matsui, L. Borsig, S. D. Rosen, M. Yaghmai, A. Varki et al., P-selectin mediates the adhesion of sickle erythrocytes to the endothelium, Blood, vol.98, issue.6, pp.1955-1962, 2001.

K. I. Ataga, A. Kutlar, J. Kanter, D. Liles, R. Cancado et al., Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease, New England Journal of Medicine, vol.376, issue.5, pp.429-439, 2017.

S. L. Etheridge, M. E. Roh, M. E. Cosgrove, V. Sangkhae, N. E. Fox et al., JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms, Proceedings of the National Academy of Sciences, vol.111, issue.6, pp.2295-2300, 2014.

R. Tiedt, H. Hao-shen, M. A. Sobas, R. Looser, S. Dirnhofer et al., Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice, Blood, vol.111, issue.8, pp.3931-3940, 2008.

, Figure 4?figure supplement 3?source data 1. Quantification of subfornical organ (SFO) vessel tightening in Pdgfb-iCreERT2:Ctnnb1Ex3fl/wt mice.

S. Hasan, C. Lacout, C. Marty, M. Cuingnet, E. Solary et al., JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFN?, Blood, vol.122, issue.8, pp.1464-1477, 2013.

S. Claxton, V. Kostourou, S. Jadeja, P. Chambon, K. Hodivala-dilke et al., Efficient, inducible Cre-recombinase activation in vascular endothelium, genesis, vol.46, issue.2, pp.74-80, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00282602

J. Rayes, M. J. Hollestelle, P. Legendre, I. Marx, P. G. De-groot et al., Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B, Blood, vol.115, issue.23, pp.4870-4877, 2010.

K. J. Livak and T. D. Schmittgen, Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2???CT Method, Methods, vol.25, issue.4, pp.402-408, 2001.

T. Barbui, G. Finazzi, A. Carobbio, J. Thiele, F. Passamonti et al., Development and validation of an International Prognostic Score of thrombosis in World Health Organization?essential thrombocythemia (IPSET-thrombosis), Blood, vol.120, issue.26, pp.5128-5133, 2012.

V. Brinkmann, U. Reichard, and C. Goosmann, Neutrophil Extracellular Traps Kill Bacteria, Science, vol.303, issue.5663, pp.1532-1535, 2004.

T. A. Fuchs, A. Brill, D. Duerschmied, D. Schatzberg, M. Monestier et al., Extracellular DNA traps promote thrombosis, Proceedings of the National Academy of Sciences, vol.107, issue.36, pp.15880-15885, 2010.

K. Tang, W. Ding, A. Höppner, C. Zhao, L. Zhang et al., The terminal phycobilisome emitter, LCM: A light-harvesting pigment with a phytochrome chromophore, Proceedings of the National Academy of Sciences, vol.112, issue.52, pp.15880-15885, 2015.

S. Massberg, L. Grahl, M. Von-bruehl, D. Manukyan, S. Pfeiler et al., Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases, Nature Medicine, vol.16, issue.8, pp.887-896, 2010.

M. Von-brühl, K. Stark, and A. Steinhart, Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo, J. Exp. Med, vol.209, issue.4, pp.819-835, 2012.

O. Wolach, R. S. Sellar, K. Martinod, D. Cherpokova, M. Mcconkey et al., Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms, Science Translational Medicine, vol.10, issue.436, p.eaan8292, 2018.

J. W. Vardiman, J. Thiele, D. A. Arber, R. D. Brunning, M. J. Borowitz et al., The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes, Blood, vol.114, issue.5, pp.937-951, 2009.

A. Alvarez-larrán, E. Arellano-rodrigo, J. C. Reverter, A. Domingo, N. Villamor et al., Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis, Annals of Hematology, vol.87, issue.4, pp.269-276, 2007.

E. Arellano-rodrigo, A. Alvarez-larrán, J. Reverter, D. Colomer, N. Villamor et al., Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence andJAK2 V617F allele burden, American Journal of Hematology, vol.84, issue.2, pp.102-108, 2009.

A. Falanga, M. Marchetti, A. Vignoli, D. Balducci, L. Russo et al., V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules, Experimental Hematology, vol.35, issue.5, pp.702-711, 2007.

M. Marchetti, E. Castoldi, H. M. Spronk, R. Van-oerle, D. Balducci et al., Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera, Blood, vol.112, issue.10, pp.4061-4068, 2008.

E. Arellano-rodrigo, A. Alvarez-larran, F. Cervantes, J. Reverter, N. Villamor et al., Increased Platelet Turnover and Platelet P-Selectin in Patients with Essential Thrombocythemia and Thrombosis., Blood, vol.104, issue.11, pp.4744-4744, 2004.

T. A. Fuchs, A. Brill, and D. D. Wagner, Neutrophil Extracellular Trap (NET) Impact on Deep Vein Thrombosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.8, pp.1777-1783, 2012.

K. Kessenbrock, M. Krumbholz, U. Schönermarck, W. Back, W. L. Gross et al., Netting neutrophils in autoimmune small-vessel vasculitis, Nature Medicine, vol.15, issue.6, pp.623-625, 2009.

S. Yalavarthi, T. J. Gould, A. N. Rao, L. F. Mazza, A. E. Morris et al., Release of Neutrophil Extracellular Traps by Neutrophils Stimulated With Antiphospholipid Antibodies: A Newly Identified Mechanism of Thrombosis in the Antiphospholipid Syndrome, Arthritis & Rheumatology, vol.67, issue.11, pp.2990-3003, 2015.

A. Carobbio, J. Thiele, F. Passamonti, E. Rumi, M. Ruggeri et al., Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients, Blood, vol.117, issue.22, pp.5857-5859, 2011.

V. Buxhofer-ausch, B. Gisslinger, M. Schalling, A. Gleiss, A. Schiefer et al., Impact of white blood cell counts at diagnosis and during follow-up in patients with essential thrombocythaemia and prefibrotic primary myelofibrosis, British Journal of Haematology, vol.179, issue.1, pp.166-169, 2016.

R. Landolfi, L. Di-gennaro, T. Barbui, V. De-stefano, G. Finazzi et al., Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera, Blood, vol.109, issue.6, pp.2446-2452, 2006.

A. Falanga, M. Marchetti, V. Evangelista, A. Vignoli, M. Licini et al., Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera, Blood, vol.96, issue.13, pp.4261-4266, 2000.

A. Falanga, M. Marchetti, A. Vignoli, D. Balducci, and T. Barbui, Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera, Experimental Hematology, vol.33, issue.5, pp.523-530, 2005.

N. Gupta, B. Edelmann, T. M. Schnoeder, F. C. Saalfeld, D. Wolleschak et al., JAK2-V617F activates ?1-integrin-mediated adhesion of granulocytes to vascular cell adhesion molecule 1, Leukemia, vol.31, issue.5, pp.1223-1226, 2017.

B. Edelmann, N. Gupta, T. M. Schnoeder, A. M. Oelschlegel, K. Shahzad et al., JAK2-V617F promotes venous thrombosis through ?1/?2 integrin activation, Journal of Clinical Investigation, vol.128, issue.10, pp.4359-4371, 2018.

R. Gangaraju, S. J. Kim, J. Song, S. Swierczek, P. Thiagarajan et al., Upregulation of Thrombo-Inflammatory Pathways May Contribute to Increased Thrombotic Risk in Polycythemia Vera and Essential Thrombocythemia, Blood, vol.128, issue.22, pp.3143-3143, 2016.

O. Wolach, R. S. Sellar, K. Martinod, D. Cherpokova, M. Mcconkey et al., Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms, Science Translational Medicine, vol.10, issue.436, p.eaan8292, 2018.

C. P. Oyarzún, A. Carestia, and P. R. Lev, Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms, Sci. Rep, vol.6, issue.1, 2016.

O. Wolach, R. S. Sellar, K. Martinod, D. Cherpokova, M. Mcconkey et al., Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms, Science Translational Medicine, vol.10, issue.436, p.eaan8292, 2018.

T. A. Fuchs, J. A. Kremer-hovinga, D. Schatzberg, D. D. Wagner, and B. Lämmle, Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies, Blood, vol.120, issue.6, pp.1157-1164, 2012.

J. I. Borissoff, I. A. Joosen, M. O. Versteylen, A. Brill, T. A. Fuchs et al., Elevated Levels of Circulating DNA and Chromatin Are Independently Associated With Severe Coronary Atherosclerosis and a Prothrombotic State, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.33, issue.8, pp.2032-2040, 2013.

, Pingré, Alexandre‐Guy

A. Guy, L. Deloison, V. Gourdou-latyszenok, S. Favre, S. Colomer et al., Étude des propriétés prothrombotiques des polynucléaires neutrophiles dans les néoplasies myéloprolifératives, JMV-Journal de Médecine Vasculaire, vol.44, issue.2, pp.135-136, 2019.

R. Favre, Le Duc de Saint-Simon en extase, Cahiers Saint Simon, vol.11, issue.1, pp.43-46, 1983.

G. W. Kennedy, Krystall, Marty [Martin M.; Count of Marty Krystall], 2003.

A. A. Bekkat, Kateb, Yacine, Yacine Boulaftali, vol.3, 2005.

, Dumoulin, Matthieu, Matthieu Mosca, vol.2, 2011.

, Thierry, Thierry, Thierry Couffinhal, vol.1, 2011.

T. C. Tyler-chloe, T. C. Tyler-chloe, T. C. Tyler-chloe, T. C. Tyler-chloe, T. C. Tyler-chloe et al., Training school Job Placement Assistance Career Training Academy, Chloé James, vol.1, p.5, 2011.

, Transforming property of an HBV-cyclin a fusion protein identified in a human hepatocellular carcinoma INSERM U370, Institut Necker, Paris, France. *CNRS UA 1158, Institut Gustave Roussy, Villejuif, France, Hepatology, vol.22, issue.4, p.A157, 1995.

D. A. Arber, A. Orazi, and R. Hasserjian, Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-2405., Blood, vol.128, issue.3, pp.462-463, 2016.

A. Falanga, M. Marchetti, A. Vignoli, D. Balducci, and T. Barbui, Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera, Experimental Hematology, vol.33, issue.5, pp.523-530, 2005.

A. Falanga, M. Marchetti, A. Vignoli, D. Balducci, L. Russo et al., V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules, Experimental Hematology, vol.35, issue.5, pp.702-711, 2007.

E. Arellano-rodrigo, A. Alvarez-larran, F. Cervantes, J. Reverter, N. Villamor et al., Increased Platelet Turnover and Platelet P-Selectin in Patients with Essential Thrombocythemia and Thrombosis., Blood, vol.104, issue.11, pp.4744-4744, 2004.

C. M. Hobbs, H. Manning, C. Bennett, L. Vasquez, S. Severin et al., JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia, Blood, vol.122, issue.23, pp.3787-3797, 2013.

L. Lamrani, C. Lacout, V. Ollivier, C. V. Denis, E. Gardiner et al., Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm, Blood, vol.124, issue.7, pp.1136-1145, 2014.

P. J. Campbell, C. Maclean, P. A. Beer, G. Buck, K. Wheatley et al., Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort, Blood, vol.120, issue.7, pp.1409-1411, 2012.

A. Carobbio, J. Thiele, F. Passamonti, E. Rumi, M. Ruggeri et al., Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients, Blood, vol.117, issue.22, pp.5857-5859, 2011.

V. Brinkmann, U. Reichard, and C. Goosmann, Neutrophil Extracellular Traps Kill Bacteria, Science, vol.303, issue.5663, pp.1532-1535, 2004.

T. A. Fuchs, A. Brill, D. Duerschmied, D. Schatzberg, M. Monestier et al., Extracellular DNA traps promote thrombosis, Proceedings of the National Academy of Sciences, vol.107, issue.36, pp.15880-15885, 2010.

K. Tang, W. Ding, A. Höppner, C. Zhao, L. Zhang et al., The terminal phycobilisome emitter, LCM: A light-harvesting pigment with a phytochrome chromophore, Proceedings of the National Academy of Sciences, vol.112, issue.52, pp.15880-15885, 2015.

T. A. Fuchs, A. Brill, and D. D. Wagner, Neutrophil Extracellular Trap (NET) Impact on Deep Vein Thrombosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.8, pp.1777-1783, 2012.

A. Brill, T. A. Fuchs, A. S. Savchenko, G. M. Thomas, K. Martinod et al., Neutrophil extracellular traps promote deep vein thrombosis in mice, Journal of Thrombosis and Haemostasis, vol.10, issue.1, pp.136-144, 2012.

M. Von-brühl, K. Stark, and A. Steinhart, Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo, J. Exp. Med, vol.209, issue.4, pp.819-835, 2012.

S. Massberg, L. Grahl, M. Von-bruehl, D. Manukyan, S. Pfeiler et al., Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases, Nature Medicine, vol.16, issue.8, pp.887-896, 2010.

O. Wolach, R. S. Sellar, K. Martinod, D. Cherpokova, M. Mcconkey et al., Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms, Science Translational Medicine, vol.10, issue.436, p.eaan8292, 2018.

S. Hasan, C. Lacout, C. Marty, M. Cuingnet, E. Solary et al., JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFN?, Blood, vol.122, issue.8, pp.1464-1477, 2013.

R. Tiedt, T. Schomber, H. Hao-shen, and R. C. Skoda, Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo, Blood, vol.109, issue.4, pp.1503-1506, 2006.

M. D. Muzumdar, B. Tasic, K. Miyamichi, L. Li, and L. Luo, A global double-fluorescent Cre reporter mouse, genesis, vol.45, issue.9, pp.593-605, 2007.

E. Passegué, E. F. Wagner, and I. L. Weissman, JunB Deficiency Leads to a Myeloproliferative Disorder Arising from Hematopoietic Stem Cells, Cell, vol.119, issue.3, pp.431-443, 2004.

S. D. Calaminus, A. Guitart, A. Sinclair, H. Schachtner, S. P. Watson et al., Lineage Tracing of Pf4-Cre Marks Hematopoietic Stem Cells and Their Progeny, PLoS ONE, vol.7, issue.12, p.e51361, 2012.

S. R. Clark, A. C. Ma, S. A. Tavener, B. Mcdonald, Z. Goodarzi et al., Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood, Nature Medicine, vol.13, issue.4, pp.463-469, 2007.

A. Guy, V. Gourdou-latyszenok, N. Le-lay, C. Peghaire, B. Kilani et al., Vascular endothelial cell expression of JAK2V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression, Haematologica, vol.104, issue.1, pp.70-81, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02995532

X. Yang, L. Li, J. Liu, B. Lv, and F. Chen, Extracellular histones induce tissue factor expression in vascular endothelial cells via TLR and activation of NF-?B and AP-1, Thrombosis Research, vol.137, pp.211-218, 2016.

A. Michels, L. L. Swystun, S. Albánez, J. Mewburn, K. Sponagle et al., Histones Induce Endothelial Von Willebrand Factor Release and Subsequent Platelet Capture in In Vitro and In Vivo Models, Blood, vol.124, issue.21, pp.2768-2768, 2014.

S. Wang, Y. Wang, V. Papayannopoulos, K. D. Metzler, A. Hakkim et al., Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps, Biochim. Biophys. Acta BBA -Gene Regul. Mech, vol.1829, issue.10, pp.677-691, 2010.

K. D. Metzler, T. A. Fuchs, W. M. Nauseef, D. Reumaux, J. Roesler et al., Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity, Blood, vol.117, issue.3, pp.953-959, 2011.

B. Engelmann and S. Massberg, Thrombosis as an intravascular effector of innate immunity, Nature Reviews Immunology, vol.13, issue.1, pp.34-45, 2012.

E. Arellano-rodrigo, A. Alvarez-larrán, J. Reverter, D. Colomer, N. Villamor et al., Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence andJAK2 V617F allele burden, American Journal of Hematology, vol.84, issue.2, pp.102-108, 2009.

S. L. Etheridge, M. E. Roh, M. E. Cosgrove, V. Sangkhae, N. E. Fox et al., JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms, Proceedings of the National Academy of Sciences, vol.111, issue.6, pp.2295-2300, 2014.

J. Etulain, K. Martinod, S. L. Wong, S. M. Cifuni, M. Schattner et al., P-selectin promotes neutrophil extracellular trap formation in mice, Blood, vol.126, issue.2, pp.242-246, 2015.

T. Asahara, H. Masuda, T. Takahashi, C. Kalka, C. Pastore et al., Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization, Circulation Research, vol.85, issue.3, pp.221-228, 1999.

K. I. Ataga, A. Kutlar, J. Kanter, D. Liles, R. Cancado et al., Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease, New England Journal of Medicine, vol.376, issue.5, pp.429-439, 2017.

P. Au, L. M. Daheron, D. G. Duda, K. S. Cohen, J. A. Tyrrell et al., Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels, Blood, vol.111, issue.3, pp.1302-1305, 2008.

F. H. Bahlmann, K. De-groot, J. Spandau, A. L. Landry, B. Hertel et al., Erythropoietin regulates endothelial progenitor cells, Blood, vol.103, issue.3, pp.921-926, 2004.

A. S. Bailey, S. Jiang, M. Afentoulis, C. I. Baumann, D. A. Schroeder et al., Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells, Blood, vol.103, issue.1, pp.13-19, 2004.

R. I. Baker and A. Manoharan, Platelet function in myeloproliferative disorders: Characterization and sequential studies show multiple platelet abnormalities, and change with time, European Journal of Haematology, vol.40, issue.3, pp.267-272, 2009.

S. J. Baker, S. G. Rane, and E. P. Reddy, Hematopoietic cytokine receptor signaling, Oncogene, vol.26, issue.47, pp.6724-6737, 2007.

T. Balligand, Y. Achouri, C. Pecquet, I. Chachoua, H. Nivarthi et al., Pathologic activation of thrombopoietin receptor and JAK2-STAT5 pathway by frameshift mutants of mouse calreticulin, Leukemia, vol.30, issue.8, pp.1775-1778, 2016.

R. M. Bandaranayake, D. Ungureanu, Y. Shan, D. E. Shaw, O. Silvennoinen et al., Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F, Nature Structural & Molecular Biology, vol.19, issue.8, pp.754-759, 2012.

T. Barbui, A. Carobbio, F. Cervantes, A. M. Vannucchi, P. Guglielmelli et al., Thrombosis in primary myelofibrosis: incidence and risk factors, Blood, vol.115, issue.4, pp.778-782, 2010.

T. Barbui, J. Thiele, F. Passamonti, E. Rumi, E. Boveri et al., Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study, Journal of Clinical Oncology, vol.29, issue.23, pp.3179-3184, 2011.

T. Barbui, G. Barosi, G. Birgegard, F. Cervantes, G. Finazzi et al., Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet, Journal of Clinical Oncology, vol.29, issue.6, pp.761-770, 2011.

T. Barbui, J. Thiele, F. Passamonti, E. Rumi, E. Boveri et al., Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome, Blood, vol.119, issue.10, pp.2239-2241, 2012.

T. Barbui, J. Thiele, A. Carobbio, F. Passamonti, E. Rumi et al., Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis, Blood, vol.120, issue.3, pp.569-571, 2012.

T. Barbui, G. Finazzi, A. Carobbio, J. Thiele, F. Passamonti et al., Development and validation of an International Prognostic Score of thrombosis in World Health Organization?essential thrombocythemia (IPSET-thrombosis), Blood, vol.120, issue.26, pp.5128-5133, 2012.

T. Barbui, J. Thiele, H. Gisslinger, G. Finazzi, A. Carobbio et al., Masked polycythemia Vera (mPV): Results of an international study, American Journal of Hematology, vol.89, issue.1, pp.52-54, 2013.

T. Barbui, J. Thiele, A. Carobbio, P. Guglielmelli, A. Rambaldi et al., Discriminating between essential thrombocythemia and masked polycythemia vera inJAK2mutated patients, American Journal of Hematology, vol.89, issue.6, pp.588-590, 2014.

T. Barbui, A. M. Vannucchi, A. Carobbio, J. Thiele, E. Rumi et al., Patterns of presentation and thrombosis outcome in patients with polycythemia vera strictly defined by WHO-criteria and stratified by calendar period of diagnosis, American Journal of Hematology, vol.90, issue.5, pp.434-437, 2015.

T. Barbui, A. M. Vannucchi, V. Buxhofer-ausch, V. De-stefano, S. Betti et al., Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia, Blood Cancer Journal, vol.5, issue.11, pp.e369-e369, 2015.

T. Barbui, A. M. Vannucchi, A. Carobbio, E. Rumi, G. Finazzi et al., The effect of arterial hypertension on thrombosis in low-risk polycythemia vera, American Journal of Hematology, vol.92, issue.1, pp.E5-E6, 2016.

G. Barosi, V. Rosti, E. Bonetti, R. Campanelli, A. Carolei et al., Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis, PLoS ONE, vol.7, issue.4, p.e35631, 2012.

G. Barosi, R. Mesa, G. Finazzi, C. Harrison, J. Kiladjian et al., Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project, Blood, vol.121, issue.23, pp.4778-4781, 2013.

J. H. Alexandre, O. Mansier, and J. F. Viallard, Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution, Leukemia, vol.29, pp.249-252, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01258918

X. Cabagnols, F. Favale, F. Pasquier, K. Messaoudi, J. P. Defour et al., Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients, Blood, vol.127, issue.3, pp.333-342, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01258942

S. D. Calaminus, A. Guitart, A. Sinclair, H. Schachtner, S. P. Watson et al., Lineage Tracing of Pf4-Cre Marks Hematopoietic Stem Cells and Their Progeny, PLoS ONE, vol.7, issue.12, p.e51361, 2012.

A. M. Campbell, M. Kashgarian, and M. J. Shlomchik, NADPH Oxidase Inhibits the Pathogenesis of Systemic Lupus Erythematosus, Science Translational Medicine, vol.4, issue.157, pp.157ra141-157ra141, 2012.

P. J. Campbell, C. Maclean, P. A. Beer, G. Buck, K. Wheatley et al., Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort, Blood, vol.120, issue.7, pp.1409-1411, 2012.

A. Carobbio, G. Finazzi, V. Guerini, O. Spinelli, F. Delaini et al., Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status, Blood, vol.109, issue.6, pp.2310-2313, 2006.

A. Carobbio, E. Antonioli, A. M. Vannucchi, F. Delaini, V. Guerini et al., Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia., Blood, vol.110, issue.11, pp.681-681, 2007.

A. Carobbio, G. Finazzi, E. Antonioli, P. Guglielmelli, A. M. Vannucchi et al., Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia, Blood, vol.112, issue.8, pp.3135-3137, 2008.

A. Carobbio, G. Finazzi, E. Antonioli, A. M. Vannucchi, G. Barosi et al., Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteria, Blood, vol.116, issue.7, pp.1051-1055, 2010.

A. Carobbio, J. Thiele, F. Passamonti, E. Rumi, M. Ruggeri et al., Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients, Blood, vol.117, issue.22, pp.5857-5859, 2011.

J. Case, L. E. Mead, W. K. Bessler, D. Prater, H. A. White et al., Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors, Experimental Hematology, vol.35, issue.7, pp.1109-1118, 2007.

P. A. Castaldi, M. C. Berndt, W. Booth, C. Gregory, H. Bull et al., Evidence for a platelet membrane defect in the myeloproliferative syndromes, Thrombosis Research, vol.27, issue.5, pp.601-609, 1982.

P. A. Castaldi, M. C. Berndt, W. Booth, C. Gregory, H. Bull et al., Evidence for a platelet membrane defect in the myeloproliferative syndromes, Thrombosis Research, vol.27, issue.5, pp.601-609, 1982.

J. Cedervall, Y. Zhang, H. Huang, L. Zhang, J. Femel et al., Neutrophil Extracellular Traps Accumulate in Peripheral Blood Vessels and Compromise Organ Function in Tumor-Bearing Animals, Cancer Research, vol.75, issue.13, pp.2653-2662, 2015.

G. Cella, M. Marchetti, F. Vianello, M. Panova-noeva, A. Vignoli et al., Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms, Thrombosis and Haemostasis, vol.104, issue.07, pp.151-156, 2010.

S. Cerquozzi and A. Tefferi, Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors, Blood Cancer Journal, vol.5, issue.11, pp.e366-e366, 2015.

F. Cervantes, A. Alvarez-larrán, E. Arellano-rodrigo, M. Granell, A. Domingo et al., Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution, Leukemia, vol.20, issue.1, pp.55-60, 2005.

I. Chachoua, C. Pecquet, M. El-khoury, H. Nivarthi, R. Albu et al., Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants, Blood, vol.127, issue.10, pp.1325-1335, 2016.

A. Charpentier, A. Lebreton, A. Rauch, A. Bauters, N. Trillot et al., Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia, Haematologica, vol.101, issue.9, pp.e365-e368, 2016.

A. K. Chauhan, D. G. Motto, C. B. Lamb, W. Bergmeier, M. Dockal et al., Systemic antithrombotic effects of ADAMTS13, Journal of Experimental Medicine, vol.203, issue.3, pp.767-776, 2006.

M. J. Chen, Y. Li, M. E. De obaldia, Q. Yang, A. D. Yzaguirre et al., Erythroid/Myeloid Progenitors and Hematopoietic Stem Cells Originate from Distinct Populations of Endothelial Cells, Cell Stem Cell, vol.9, issue.6, pp.541-552, 2011.

C. Chim, Y. Kwong, A. Lie, S. Ma, C. Chan et al., Long-term Outcome of 231 Patients With Essential Thrombocythemia, Archives of Internal Medicine, vol.165, issue.22, p.2651, 2005.

J. Cho, B. C. Furie, S. R. Coughlin, and B. Furie, A critical role for extracellular protein disulfide isomerase during thrombus formation in mice, Journal of Clinical Investigation, 2008.

K. Choi, M. Kennedy, A. Kazarov, J. C. Papadimitriou, and G. Keller, A common precursor for hematopoietic and endothelial cells, Development, vol.8, 1998.

O. A. Chow, M. Von-köckritz-blickwede, A. T. Bright, M. E. Hensler, A. S. Zinkernagel et al., Statins Enhance Formation of Phagocyte Extracellular Traps, Cell Host & Microbe, vol.8, issue.5, pp.445-454, 2010.

S. R. Clark, A. C. Ma, S. A. Tavener, B. Mcdonald, Z. Goodarzi et al., Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood, Nature Medicine, vol.13, issue.4, pp.463-469, 2007.

D. Colaizzo, L. Amitrano, L. Iannaccone, P. Vergura, F. Cappucci et al., Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings, Journal of Medical Genetics, vol.44, issue.6, pp.412-416, 2007.

E. S. Connolly, C. J. Winfree, C. J. Prestigiacomo, S. C. Kim, T. F. Choudhri et al., Exacerbation of Cerebral Injury in Mice That Express the P-Selectin Gene, Circulation Research, vol.81, issue.3, pp.304-310, 1997.

S. Cortelazzo, P. Viero, G. Finazzi, A. D'emilio, F. Rodeghiero et al., Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia., Journal of Clinical Oncology, vol.8, issue.3, pp.556-562, 1990.

S. Cortelazzo, P. Viero, G. Finazzi, A. D'emilio, F. Rodeghiero et al., Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia., Journal of Clinical Oncology, vol.8, issue.3, pp.556-562, 1990.

S. Cortelazzo, G. Finazzi, M. Ruggeri, O. Vestri, M. Galli et al., Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis, New England Journal of Medicine, vol.332, issue.17, pp.1132-1137, 1995.

E. Crisà, E. Venturino, R. Passera, M. Prina, P. Schinco et al., A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs, Annals of Hematology, vol.89, issue.7, pp.691-699, 2010.

J. R. Crosby, W. E. Kaminski, G. Schatteman, P. J. Martin, E. W. Raines et al., Endothelial Cells of Hematopoietic Origin Make a Significant Contribution to Adult Blood Vessel Formation, Circulation Research, vol.87, issue.9, pp.728-730, 2000.

M. Cugno, A. V. Marzano, M. Lorini, V. Carbonelli, and A. Tedeschi, Enhanced Tissue Factor Expression by Blood Eosinophils from Patients with Hypereosinophilia: A Possible Link with Thrombosis, PLoS ONE, vol.9, issue.11, p.e111862, 2014.

R. Darbousset, G. M. Thomas, S. Mezouar, C. Frère, R. Bonier et al., Tissue factor?positive neutrophils bind to injured endothelial wall and initiate thrombus formation, Blood, vol.120, issue.10, pp.2133-2143, 2012.

R. Darbousset, C. Delierneux, S. Mezouar, A. Hego, C. Lecut et al., P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice, Blood, vol.124, issue.16, pp.2575-2585, 2014.

J. C. Davis, S. Manzi, C. Yarboro, J. Rairie, I. Mcinnes et al., Recombinant human Dnase I (rhDNase) in patients with lupus nephritis, Lupus, vol.8, issue.1, pp.68-76, 1999.

M. De-grandis, M. Cambot, M. Wautier, B. Cassinat, C. Chomienne et al., JAK2V617F activates Lu/BCAM-mediated red cell adhesion in polycythemia vera through an EpoR-independent Rap1/Akt pathway, Blood, vol.121, issue.4, pp.658-665, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00821109

D. Meyer, S. F. Suidan, G. L. Fuchs, T. A. Monestier, M. Wagner et al., , 2012.

S. F. De-meyer, G. L. Suidan, T. A. Fuchs, M. Monestier, and D. D. Wagner, Extracellular Chromatin Is an Important Mediator of Ischemic Stroke in Mice, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.8, pp.1884-1891, 2012.

D. Meyer, S. F. Savchenko, A. S. Haas, M. S. Schatzberg, D. Carroll et al., Protective antiinflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice, Blood, vol.120, pp.5217-5223, 2012.

M. De-palma, M. A. Venneri, C. Roca, and L. Naldini, Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells, Nature Medicine, vol.9, issue.6, pp.789-795, 2003.

V. De-stefano, T. Za, E. Rossi, A. M. Vannucchi, M. Ruggeri et al., Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments, Haematologica, vol.93, issue.3, pp.372-380, 2008.

V. De-stefano, T. Za, E. Rossi, A. M. Vannucchi, M. Ruggeri et al., Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments, Haematologica, vol.93, issue.3, pp.372-380, 2008.

V. De-stefano, A. M. Vannucchi, M. Ruggeri, F. Cervantes, A. Alvarez-larrán et al., Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients, Blood Cancer Journal, vol.6, issue.11, pp.e493-e493, 2016.

J. Defour, I. Chachoua, C. Pecquet, and S. N. Constantinescu, Oncogenic activation of MPL/thrombopoietin receptor by 17 mutations at W515: implications for myeloproliferative neoplasms, Leukemia, vol.30, issue.5, pp.1214-1216, 2015.

F. Delhommeau, S. Dupont, V. D. Valle, C. James, S. Trannoy et al., Mutation inTET2in Myeloid Cancers, New England Journal of Medicine, vol.360, issue.22, pp.2289-2301, 2009.

M. Demers and D. Wagner, NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis, Seminars in Thrombosis and Hemostasis, vol.40, issue.03, pp.277-283, 2014.

M. Demers, D. S. Krause, D. Schatzberg, K. Martinod, J. R. Voorhees et al., Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis, Proceedings of the National Academy of Sciences, vol.109, issue.32, pp.13076-13081, 2012.

A. D'emilio, R. Battista, E. Dini, M. Messinezy, T. C. Pearson et al., TREATMENT OF PRIMARY PROLIFERATIVE POLYCYTHAEMIA BY VENESECTION AND BUSULPHAN, British Journal of Haematology, vol.65, issue.1, pp.121-122, 1987.

D. Minno, M. N. Ageno, W. Lupoli, R. Conte, G. Van-es et al., Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials, Eur. Respir. J, vol.50, p.1701097, 2017.

D. Nisio, M. Barbui, T. Gennaro, L. D. Borrelli, G. Finazzi et al., The haematocrit and platelet target in polycythemia vera, Br. J. Haematol, vol.136, pp.249-259, 2006.

J. A. Diaz, T. A. Fuchs, T. O. Jackson, J. A. Kremer-hovinga, B. Lämmle et al., Plasma DNA is elevated in patients with deep vein thrombosis, Journal of Vascular Surgery: Venous and Lymphatic Disorders, vol.1, issue.4, pp.341-348.e1, 2013.

I. Dienava-verdoold, M. R. Marchetti, L. C. Te-boome, L. Russo, A. Falanga et al., Platelet-mediated proteolytic down regulation of the anticoagulant activity of protein S in individuals with haematological malignancies, Thrombosis and Haemostasis, vol.107, issue.03, pp.468-476, 2012.

J. Dillinger, C. B. Sollier, G. Sideris, E. Ronez, P. Henry et al., Twice daily aspirin to improve biological aspirin efficacy in patients with essential thrombocytemia, Thrombosis Research, vol.129, issue.1, pp.91-94, 2012.

S. Dimmeler, A. Aicher, M. Vasa, C. Mildner-rihm, K. Adler et al., HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway, Journal of Clinical Investigation, vol.108, issue.3, pp.391-397, 2001.

P. Dombi, Á. Illés, J. Demeter, L. Homor, Z. Simon et al., Anagrelide reduces thrombotic risk in essential thrombocythaemia vs. hydroxyurea plus aspirin, European Journal of Haematology, vol.98, issue.2, pp.106-111, 2016.

G. Douglas, C. Harrison, C. Forsyth, M. Bennett, W. Stevenson et al., Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea, Leukemia & Lymphoma, vol.58, issue.1, pp.89-95, 2016.

J. Duchemin, V. Ugo, J. Ianotto, L. Lecucq, B. Mercier et al., Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms, Thrombosis Research, vol.126, issue.3, pp.238-242, 2010.

B. Edelmann, N. Gupta, T. M. Schnoeder, A. M. Oelschlegel, K. Shahzad et al., JAK2-V617F promotes venous thrombosis through ?1/?2 integrin activation, Journal of Clinical Investigation, vol.128, issue.10, pp.4359-4371, 2018.

M. A. Elliott and A. Tefferi, Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia, British Journal of Haematology, vol.128, issue.3, pp.275-290, 2005.

P. J. Engel, H. Johnson, R. P. Baughman, and A. I. Richards, High-Output Heart Failure Associated with Anagrelide Therapy for Essential Thrombocytosis, Annals of Internal Medicine, vol.143, issue.4, p.311, 2005.

B. Engelmann and S. Massberg, Thrombosis as an intravascular effector of innate immunity, Nature Reviews Immunology, vol.13, issue.1, pp.34-45, 2012.

C. T. Esmon and N. L. Esmon, The Link Between Vascular Features and Thrombosis, Annual Review of Physiology, vol.73, issue.1, pp.503-514, 2011.

S. L. Etheridge, M. E. Roh, M. E. Cosgrove, V. Sangkhae, N. E. Fox et al., JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms, Proceedings of the National Academy of Sciences, vol.111, issue.6, pp.2295-2300, 2014.

J. Etulain, K. Martinod, S. L. Wong, S. M. Cifuni, M. Schattner et al., P-selectin promotes neutrophil extracellular trap formation in mice, Blood, vol.126, issue.2, pp.242-246, 2015.

A. Falanga, M. Marchetti, V. Evangelista, A. Vignoli, M. Licini et al., Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera, Blood, vol.96, issue.13, pp.4261-4266, 2000.

A. Falanga, M. Marchetti, A. Vignoli, D. Balducci, and T. Barbui, Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera, Experimental Hematology, vol.33, issue.5, pp.523-530, 2005.

A. Falanga, M. Marchetti, D. Balducci, A. Vignoli, L. Russo et al., Distinct Hemostatic Profile of Leukocytes in Essential Thrombocythemia (ET) Carrying the JAK2 V617F Mutation., Blood, vol.106, issue.11, pp.378-378, 2005.

A. Falanga, M. Marchetti, A. Vignoli, D. Balducci, L. Russo et al., V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules, Experimental Hematology, vol.35, issue.5, pp.702-711, 2007.

B. Fang, C. Zheng, L. Liao, Q. Han, Z. Sun et al., Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics, Blood, vol.105, issue.7, pp.2733-2740, 2005.

P. Fang, X. Li, J. Dai, L. Cole, J. A. Camacho et al., Immune cell subset differentiation and tissue inflammation, Journal of Hematology & Oncology, vol.11, issue.1, 2018.

S. Fang, J. Wei, N. Pentinmikko, H. Leinonen, and P. Salven, Generation of Functional Blood Vessels from a Single c-kit+ Adult Vascular Endothelial Stem Cell, PLoS Biology, vol.10, issue.10, p.e1001407, 2012.

H. J. Fehling, G. Lacaud, A. Kubo, M. Kennedy, S. Robertson et al., Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation, Development, vol.130, issue.17, pp.4217-4227, 2003.

J. Feng, B. A. Witthuhn, T. Matsuda, F. Kohlhuber, I. M. Kerr et al., Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop., Molecular and Cellular Biology, vol.17, issue.5, pp.2497-2501, 1997.

G. Finazzi, V. Caruso, R. Marchioli, G. Capnist, T. Chisesi et al., Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study, Blood, vol.105, issue.7, pp.2664-2670, 2005.

M. C. Finazzi, A. Carobbio, F. Cervantes, I. M. Isola, A. M. Vannucchi et al., CALR mutation, MPL mutation and triple negativity identify patients with the lowest vascular risk in primary myelofibrosis, Leukemia, vol.29, issue.5, pp.1209-1210, 2014.

A. Fiorini, P. Chiusolo, E. Rossi, T. Za, D. G. De-ritis et al., Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms, American Journal of Hematology, vol.84, issue.2, pp.126-127, 2009.

M. Fleischhacker and B. Schmidt, Circulating nucleic acids (CNAs) and cancer?A survey, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1775, issue.1, pp.181-232, 2007.

J. E. Freedman and J. Loscalzo, Nitric oxide and its relationship to thrombotic disorders, Journal of Thrombosis and Haemostasis, vol.1, issue.6, pp.1183-1188, 2003.

S. M. Fruchtman, K. Mack, M. E. Kaplan, P. Peterson, P. D. Berk et al., From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera, Semin. Hematol, vol.34, pp.17-23, 1997.

T. A. Fuchs, A. Brill, D. Duerschmied, D. Schatzberg, M. Monestier et al., Extracellular DNA traps promote thrombosis, Proceedings of the National Academy of Sciences, vol.107, issue.36, pp.15880-15885, 2010.

T. A. Fuchs, A. A. Bhandari, and D. D. Wagner, Histones induce rapid and profound thrombocytopenia in mice, Blood, vol.118, issue.13, pp.3708-3714, 2011.

T. A. Fuchs, A. Brill, and D. D. Wagner, Neutrophil Extracellular Trap (NET) Impact on Deep Vein Thrombosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.8, pp.1777-1783, 2012.

T. A. Fuchs, J. A. Kremer-hovinga, D. Schatzberg, D. D. Wagner, and B. Lämmle, Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies, Blood, vol.120, issue.6, pp.1157-1164, 2012.

T. A. Fuchs, J. A. Kremer-hovinga, D. Schatzberg, D. D. Wagner, and B. Lämmle, Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies, Blood, vol.120, issue.6, pp.1157-1164, 2012.

B. Furie and B. C. Furie, Molecular and cellular biology of blood coagulation, N. Engl. J. Med, vol.326, pp.800-806, 1992.

B. Furie and B. C. Furie, Mechanisms of Thrombus Formation, New England Journal of Medicine, vol.359, issue.9, pp.938-949, 2008.

M. Furlan, R. Robles, and B. Lamie, Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis, Blood, vol.87, issue.10, pp.4223-4234, 1996.

A. J. Gale and D. Rozenshteyn, Cathepsin G, a leukocyte protease, activates coagulation factor VIII, Thromb. Haemost, vol.99, pp.44-51, 2008.

L. Galligan, W. Livingstone, Y. Volkov, K. Hokamp, C. Murphy et al., Characterization of protein C receptor expression in monocytes, British Journal of Haematology, vol.115, issue.2, pp.408-414, 2001.

R. Gangaraju, S. J. Kim, J. Song, S. Swierczek, P. Thiagarajan et al., Upregulation of Thrombo-Inflammatory Pathways May Contribute to Increased Thrombotic Risk in Polycythemia Vera and Essential Thrombocythemia, Blood, vol.128, issue.22, pp.3143-3143, 2016.

N. Gangat, E. A. Wassie, T. L. Lasho, C. Finke, R. P. Ketterling et al.,

A. P. Wolanskyj, M. Maffioli, and R. Casalone, Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history, Eur. J. Haematol, vol.94, pp.31-36, 2014.

R. J. Garcia, L. Francis, M. Dawood, Z. Lai, S. V. Faraone et al., Brief Report: Attention Deficit and Hyperactivity Disorder Scores Are Elevated and Respond toN-Acetylcysteine Treatment in Patients With Systemic Lupus Erythematosus, Arthritis & Rheumatism, vol.65, issue.5, pp.1313-1318, 2013.

J. E. Geddings and N. Mackman, Tumor-derived tissue factor?positive microparticles and venous thrombosis in cancer patients, Blood, vol.122, issue.11, pp.1873-1880, 2013.

A. Gennery, Recent advances in understanding and treating chronic granulomatous disease, F1000Research, vol.6, p.1427, 2017.

M. Gill, S. Dias, K. Hattori, M. L. Rivera, D. Hicklin et al., Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+AC133+Endothelial Precursor Cells, Circulation Research, vol.88, issue.2, pp.167-174, 2001.

F. Girodon, F. Dutrillaux, J. Broséus, M. Mounier, V. Goussot et al., Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: a population-based study of 311 patients, Leukemia, vol.24, issue.4, pp.900-903, 2010.

. Gruppo-italiano-studio-policitemia*, Polycythemia Vera: The Natural History of 1213 Patients Followed for 20 Years, Annals of Internal Medicine, vol.123, issue.9, p.656, 1995.

H. Gisslinger, M. Gotic, J. Holowiecki, M. Penka, J. Thiele et al., Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial, Blood, vol.121, issue.10, pp.1720-1728, 2013.

C. B. Glaser, J. Morser, J. H. Clarke, E. Blasko, K. Mclean et al., Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation., Journal of Clinical Investigation, vol.90, issue.6, pp.2565-2573, 1992.

M. B. Grant, W. S. May, S. Caballero, G. A. Brown, S. M. Guthrie et al., Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization, Nature Medicine, vol.8, issue.6, pp.607-612, 2002.

M. Griesshammer, G. Saydam, F. Palandri, G. Benevolo, M. Egyed et al., Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial, Annals of Hematology, vol.97, issue.9, pp.1591-1600, 2018.

A. Guadall, E. Lesteven, G. Letort, S. Awan-toor, M. Delord et al., Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features, Thrombosis and Haemostasis, vol.118, issue.09, pp.1586-1599, 2018.

P. Guglielmelli, A. Pancrazzi, G. Bergamaschi, V. Rosti, L. Villani et al., Anaemia characterises patients with myelofibrosis harbouring MplW515L/Kmutation, British Journal of Haematology, vol.137, issue.3, pp.244-247, 2007.

E. Gunsilius, H. Duba, A. L. Petzer, C. M. Kahler, K. Grunewald et al., Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells, The Lancet, vol.355, issue.9216, pp.1688-1691, 2000.

N. Gupta, B. Edelmann, T. M. Schnoeder, F. C. Saalfeld, D. Wolleschak et al., JAK2-V617F activates ?1-integrin-mediated adhesion of granulocytes to vascular cell adhesion molecule 1, Leukemia, vol.31, issue.5, pp.1223-1226, 2017.

A. Guy, V. Gourdou-latyszenok, N. Le-lay, C. Peghaire, B. Kilani et al., Vascular endothelial cell expression of JAK2V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression, Haematologica, vol.104, issue.1, pp.70-81, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02995532

M. Haider, N. Gangat, T. Lasho, A. K. Abou-hussein, Y. C. Elala et al., Validation of the revised international prognostic score of thrombosis for essential thrombocythemia (IPSET-thrombosis) in 585 Mayo clinic patients, American Journal of Hematology, vol.91, issue.4, pp.390-394, 2016.

K. K. Hamilton and P. J. Sims, Changes in cytosolic Ca2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. Study of microcarrier cell monolayers using the fluorescent probe indo-1., Journal of Clinical Investigation, vol.79, issue.2, pp.600-608, 1987.

C. N. Harrison, P. J. Campbell, G. Buck, K. Wheatley, C. L. East et al., Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia, New England Journal of Medicine, vol.353, issue.1, pp.33-45, 2005.

C. N. Harrison, A. J. Mead, A. Panchal, S. Fox, C. Yap et al., Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide, Blood, vol.130, issue.17, pp.1889-1897, 2017.

M. S. Harrison, I. J. Robinson, and P. Mac, Platelets, vol.8, pp.379-384, 1997.

S. Hasan, C. Lacout, C. Marty, M. Cuingnet, E. Solary et al., JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFN?, Blood, vol.122, issue.8, pp.1464-1477, 2013.

M. Haubitz, M. Gerlach, H. J. Kruse, and R. Brunkhorst, Endothelial tissue factor stimulation by proteinase 3 and elastase, Clinical & Experimental Immunology, vol.126, issue.3, pp.584-588, 2001.

H. He, J. Xu, C. M. Warren, D. Duan, X. Li et al., Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages, Blood, vol.120, issue.15, pp.3152-3162, 2012.

H. He, J. Xu, C. M. Warren, D. Duan, X. Li et al., Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages, Blood, vol.120, issue.15, pp.3152-3162, 2012.

B. Heissig, K. Hattori, S. Dias, M. Friedrich, B. Ferris et al., Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand, Cell, vol.109, issue.5, pp.625-637, 2002.

R. Helman, W. D. Pereira, L. C. Marti, P. V. Campregher, R. D. Puga et al., Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm, British Journal of Haematology, vol.180, issue.3, pp.443-445, 2016.

S. Hemmers, J. R. Teijaro, S. Arandjelovic, and K. A. Mowen, PAD4-Mediated Neutrophil Extracellular Trap Formation Is Not Required for Immunity against Influenza Infection, PLoS ONE, vol.6, issue.7, p.e22043, 2011.

J. M. Herbert, P. Savi, M. C. Laplace, and A. Lale, IL-4 inhibits LPS-, IL-1?- and TNF?-induced expression of tissue factor in endothelial cells and monocytes, FEBS Letters, vol.310, issue.1, pp.31-33, 1992.

J. Hernández-boluda, E. Arellano-rodrigo, F. Cervantes, A. Alvarez-larrán, M. Gómez et al., Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia, Annals of Hematology, vol.94, issue.6, pp.911-918, 2015.

P. Hildbrand, V. Cirulli, R. C. Prinsen, K. A. Smith, B. E. Torbett et al., The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors, Blood, vol.104, issue.7, pp.2010-2019, 2004.

J. M. Hill, G. Zalos, J. P. Halcox, W. H. Schenke, M. A. Waclawiw et al., Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk, New England Journal of Medicine, vol.348, issue.7, pp.593-600, 2003.

J. Himber, D. Kling, J. T. Fallon, Y. Nemerson, and M. A. Riederer, In situ localization of tissue factor in human thrombi, Blood, vol.99, issue.11, pp.4249-4250, 2002.

K. K. Hirschi, Hemogenic endothelium during development and beyond, Blood, vol.119, issue.21, pp.4823-4827, 2012.

W. K. Ho and F. S. Hong, CALR exon 9 mutations in idiopathic splanchnic vein thrombosis in an Australian cohort, Thrombosis Research, vol.150, pp.51-52, 2017.

C. M. Hobbs, H. Manning, C. Bennett, L. Vasquez, S. Severin et al., JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia, Blood, vol.122, issue.23, pp.3787-3797, 2013.

H. Hock, M. J. Hamblen, H. M. Rooke, J. W. Schindler, S. Saleque et al., Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells, Nature, vol.431, issue.7011, pp.1002-1007, 2004.

H. Hock, M. J. Hamblen, H. M. Rooke, J. W. Schindler, S. Saleque et al., Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells, Nature, vol.431, issue.7011, pp.1002-1007, 2004.

L. Holmgren, A. Bergsmedh, and A. Spetz, Horizontal Transfer of DNA by the Uptake of Apoptotic Bodies, Vox Sanguinis, vol.83, pp.305-306, 2002.

J. Hur, C. Yoon, H. Kim, J. Choi, H. Kang et al., Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.2, pp.288-293, 2004.

M. Hurtado-nedelec, M. Csillag-grange, T. Boussetta, S. A. Belambri, M. Fay et al., Increased reactive oxygen species production and p47phox phosphorylation in neutrophils from myeloproliferative disorders patients with JAK2 (V617F) mutation, Haematologica, vol.98, issue.10, pp.1517-1524, 2013.

J. Ianotto, M. Couturier, H. Galinat, D. Mottier, C. Berthou et al., Administration of direct oral anticoagulants in patients with myeloproliferative neoplasms, International Journal of Hematology, vol.106, issue.4, pp.517-521, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02049488

D. A. Ingram, L. E. Mead, H. Tanaka, V. Meade, A. Fenoglio et al., Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood, Blood, vol.104, issue.9, pp.2752-2760, 2004.

D. A. Ingram, L. E. Mead, D. B. Moore, W. Woodard, A. Fenoglio et al., Vessel wall?derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells, Blood, vol.105, issue.7, pp.2783-2786, 2005.

D. A. Ingram, N. M. Caplice, and M. C. Yoder, Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells, Blood, vol.106, issue.5, pp.1525-1531, 2005.

K. Itagaki, E. Kaczmarek, Y. T. Lee, I. T. Tang, B. Isal et al., Mitochondrial DNA Released by Trauma Induces Neutrophil Extracellular Traps, PLOS ONE, vol.10, issue.3, p.e0120549, 2015.

T. Ito, K. Kawahara, T. Nakamura, S. Yamada, T. Nakamura et al., High-mobility group box 1 protein promotes development of microvascular thrombosis in rats, Journal of Thrombosis and Haemostasis, vol.5, issue.1, pp.109-116, 2006.

A. Iurlo, D. Cattaneo, U. Gianelli, E. Fermo, C. Augello et al., Molecular analyses in the diagnosis of myeloproliferative neoplasm-related splanchnic vein thrombosis, Annals of Hematology, vol.94, issue.5, pp.881-882, 2014.

K. A. Jackson, S. M. Majka, H. Wang, J. Pocius, C. J. Hartley et al., Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells, Journal of Clinical Investigation, vol.107, issue.11, pp.1395-1402, 2001.

A. Jadli, B. Kulkarni, K. Ghosh, and S. Shetty, Non conventional mutations associated with myeloproliferative disorders are absent in splanchnic venous thrombosis cases, Liver International, vol.32, issue.10, pp.1596-1597, 2012.

S. Jahr, H. Hentze, S. Englisch, D. Hardt, F. O. Fackelmayer et al.,

, Figure 2: Lithocholic acid (LCA) induces apoptotic and necrotic death of PC-3 and DU-145 prostate cancer cells., Cancer Res, vol.8

C. James, V. Ugo, J. Le-couédic, J. Staerk, F. Delhommeau et al., A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera, Nature, vol.434, issue.7037, pp.1144-1148, 2005.

M. K. Jensen, P. De-nully-brown, B. V. Lund, O. J. Nielsen, and H. C. Hasselbalch, Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders, British Journal of Haematology, vol.110, issue.1, pp.116-124, 2000.

M. K. Jensen, P. De-nully-brown, B. V. Lund, O. J. Nielsen, and H. C. Hasselbalch, Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders, British Journal of Haematology, vol.110, issue.1, pp.116-124, 2000.

M. K. Jensen, P. De-nully-brown, S. Thorsen, and H. C. Hasselbalch, Frequent occurrence of anticardiolipin antibodies, Factor V Leiden mutation, and perturbed endothelial function in chronic myeloproliferative disorders, American Journal of Hematology, vol.69, issue.3, pp.185-191, 2002.

S. Jiang, L. Walker, M. Afentoulis, D. A. Anderson, L. Jauron-mills et al., Transplanted human bone marrow contributes to vascular endothelium, Proceedings of the National Academy of Sciences, vol.101, issue.48, pp.16891-16896, 2004.

M. Jiménez-alcázar, A. Limacher, R. Panda, M. Méan, J. Bitterling et al., Circulating extracellular DNA is an independent predictor of mortality in elderly patients with venous thromboembolism, PLOS ONE, vol.13, issue.2, p.e0191150, 2018.

S. K. Jorch and P. Kubes, An emerging role for neutrophil extracellular traps in noninfectious disease, Nature Medicine, vol.23, issue.3, pp.279-287, 2017.

H. Kamihata, H. Matsubara, T. Nishiue, S. Fujiyama, Y. Tsutsumi et al., Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines, Circulation, vol.104, issue.9, pp.1046-1052, 2001.

C. Kannemeier, A. Shibamiya, F. Nakazawa, H. Trusheim, C. Ruppert et al., Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation, Proceedings of the National Academy of Sciences, vol.104, issue.15, pp.6388-6393, 2007.

M. Kaplar, J. Kappelmayer, A. Kiss, K. Szabo, and M. Udvardy, Increased leukocyteplatelet adhesion in chronic myeloproliferative disorders with high platelet counts, Platelets, vol.11, pp.183-184, 2000.

A. Karlsson and C. Dahlgren, Assembly and Activation of the Neutrophil NADPH Oxidase in Granule Membranes, Antioxidants & Redox Signaling, vol.4, issue.1, pp.49-60, 2002.

A. Kawamoto, H. Gwon, H. Iwaguro, J. Yamaguchi, S. Uchida et al., Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia, Circulation, vol.103, issue.5, pp.634-637, 2001.

K. Kessenbrock, M. Krumbholz, U. Schönermarck, W. Back, W. L. Gross et al., Netting neutrophils in autoimmune small-vessel vasculitis, Nature Medicine, vol.15, issue.6, pp.623-625, 2009.

J. Kiladjian, B. Cassinat, S. Chevret, P. Turlure, N. Cambier et al., Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera, Blood, vol.112, issue.8, pp.3065-3072, 2008.

J. Kiladjian, S. Chevret, C. Dosquet, C. Chomienne, and J. Rain, Treatment of Polycythemia Vera With Hydroxyurea and Pipobroman: Final Results of a Randomized Trial Initiated in 1980, Journal of Clinical Oncology, vol.29, issue.29, pp.3907-3913, 2011.

B. Kilani, J. Vieira-dias, V. Gourdou-latyszenok, E. Lippert, R. Sewduth et al., Consequences of the Presence of the JAK2V617F Mutation in Endothelial Cells: Towards a Better Understanding of the Increased Angiogenesis in Myeloproliferative Neoplasms, Blood, vol.124, issue.21, pp.102-102, 2014.

K. Kim, S. Kwon, J. Yun, H. Jeong, H. Kim et al., STAT3 activation in endothelial cells is important for tumor metastasis via increased cell adhesion molecule expression, Oncogene, vol.36, issue.39, pp.5445-5459, 2017.

S. Kinder, T. E. Tsang, G. A. Quinlan, A. Hadjantonakis, A. Nagy et al., , 1999.

K. Kirito, M. Sakamoto, and N. Enomoto, Elevation of the Hepatitis B Virus DNA during the Treatment of Polycythemia Vera with the JAK Kinase Inhibitor Ruxolitinib, Internal Medicine, vol.55, issue.10, pp.1341-1344, 2016.

K. Kissa and P. Herbomel, Blood stem cells emerge from aortic endothelium by a novel type of cell transition, Nature, vol.464, issue.7285, pp.112-115, 2010.

J. Kissova, P. Ovesna, A. Bulikova, J. Zav?elova, and M. Penka, Increasing procoagulant activity of circulating microparticles in patients with Philadelphia-negative myeloproliferative neoplasms, Blood Coagulation & Fibrinolysis, vol.26, issue.4, pp.448-453, 2015.

J. Kittur, R. A. Knudson, T. L. Lasho, C. M. Finke, N. Gangat et al., Clinical correlates ofJAK2V617F allele burden in essential thrombocythemia, Cancer, vol.109, issue.11, pp.2279-2284, 2007.

T. Klampfl, H. Gisslinger, A. S. Harutyunyan, H. Nivarthi, E. Rumi et al., Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms, New England Journal of Medicine, vol.369, issue.25, pp.2379-2390, 2013.

J. S. Knight, W. Zhao, W. Luo, V. Subramanian, A. A. O?dell et al., Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus, Journal of Clinical Investigation, vol.123, issue.7, pp.2981-2993, 2013.

J. S. Knight, W. Luo, A. A. O?dell, S. Yalavarthi, W. Zhao et al., Peptidylarginine Deiminase Inhibition Reduces Vascular Damage and Modulates Innate Immune Responses in Murine Models of Atherosclerosis, Circulation Research, vol.114, issue.6, pp.947-956, 2014.

J. S. Knight, V. Subramanian, A. A. O'dell, S. Yalavarthi, W. Zhao et al., Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lprmice, Annals of the Rheumatic Diseases, vol.74, issue.12, pp.2199-2206, 2014.

I. Kogan, D. Chap, R. Hoffman, E. Axelman, B. Brenner et al., JAK-2 V617F mutation increases heparanase procoagulant activity, Thrombosis and Haemostasis, vol.115, issue.01, pp.73-80, 2016.

E. Kolaczkowska, C. N. Jenne, B. G. Surewaard, A. Thanabalasuriar, W. Lee et al., Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature, Nature Communications, vol.6, issue.1, 2015.

O. Kollet, A. Spiegel, A. Peled, I. Petit, T. Byk et al., Rapid and efficient homing of human CD34+CD38?/lowCXCR4+stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2mnull mice, Blood, vol.97, issue.10, pp.3283-3291, 2001.

M. Koren-michowitz, J. Landman, Y. Cohen, N. Rahimi-levene, O. Salomon et al., JAK2V617F allele burden is associated with transformation to myelofibrosis, Leukemia & Lymphoma, vol.53, issue.11, pp.2210-2213, 2012.

A. Kornberg, N. Rahimi-levene, R. Yona, A. Mor, and E. A. Rachmilewitz, Enhanced generation of monocyte tissue factor and increased plasma prothrombin fragment1+2 levels in patients with polycythemia vera: Mechanism of activation of blood coagulation, American Journal of Hematology, vol.56, issue.1, pp.5-11, 1997.

A. Kornberg, N. Rahimi-levene, R. Yona, A. Mor, and E. A. Rachmilewitz, Enhanced generation of monocyte tissue factor and increased plasma prothrombin fragment1+2 levels in patients with polycythemia vera: Mechanism of activation of blood coagulation, American Journal of Hematology, vol.56, issue.1, pp.5-11, 1997.

R. Kralovics, F. Passamonti, A. S. Buser, S. Teo, R. Tiedt et al., A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders, New England Journal of Medicine, vol.352, issue.17, pp.1779-1790, 2005.

E. T. Kuriakose, S. Gjoni, Y. L. Wang, R. Baumann, A. V. Jones et al., JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drug, Haematologica, vol.98, issue.11, pp.e135-e137, 2013.

C. Lacout, D. F. Pisani, M. Tulliez, F. M. Gachelin, W. Vainchenker et al., JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis, Blood, vol.108, issue.5, pp.1652-1660, 2006.
URL : https://hal.archives-ouvertes.fr/hal-03009103

Z. Lai, R. Hanczko, E. Bonilla, T. N. Caza, B. Clair et al., N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial, Arthritis & Rheumatism, vol.64, issue.9, pp.2937-2946, 2012.

L. Lamrani, C. Lacout, V. Ollivier, C. V. Denis, E. Gardiner et al., Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm, Blood, vol.124, issue.7, pp.1136-1145, 2014.

S. Lancellotti, A. Dragani, P. Ranalli, G. Petrucci, M. Basso et al., Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count, Journal of Thrombosis and Haemostasis, vol.13, issue.7, pp.1226-1237, 2015.

C. Lancrin, P. Sroczynska, C. Stephenson, T. Allen, V. Kouskoff et al., The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage, Nature, vol.457, issue.7231, pp.892-895, 2009.

C. Lancrin, M. Mazan, M. Stefanska, R. Patel, M. Lichtinger et al., GFI1 and GFI1B control the loss of endothelial identity of hemogenic endothelium during hematopoietic commitment, Blood, vol.120, issue.2, pp.314-322, 2012.

R. Landolfi, G. Ciabattoni, P. Patrignani, M. A. Castellana, E. Pogliani et al., Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo [see comments], Blood, vol.80, issue.8, pp.1965-1971, 1992.

R. Landolfi, B. Rocca, and C. Patrono, Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment, Critical Reviews in Oncology/Hematology, vol.20, issue.3, pp.203-222, 1995.

R. Landolfi, R. Marcholi, and J. Kutti, Efficacy and safety of low-dose aspirin in polycythemia vera, ACC Current Journal Review, vol.13, issue.4, p.10, 2004.

R. Landolfi, L. Di-gennaro, T. Barbui, V. De-stefano, G. Finazzi et al., Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera, Blood, vol.109, issue.6, pp.2446-2452, 2006.

M. J. Lapponi, A. Carestia, V. I. Landoni, L. Rivadeneyra, J. Etulain et al., Regulation of Neutrophil Extracellular Trap Formation by Anti-Inflammatory Drugs, Journal of Pharmacology and Experimental Therapeutics, vol.345, issue.3, pp.430-437, 2013.

U. Laufs, N. Werner, A. Link, M. Endres, S. Wassmann et al., Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis, Circulation, vol.109, issue.2, pp.220-226, 2004.

S. H. Lee, P. L. Wolf, R. Escudero, R. Deutsch, S. W. Jamieson et al., Early Expression of Angiogenesis Factors in Acute Myocardial Ischemia and Infarction, New England Journal of Medicine, vol.342, issue.9, pp.626-633, 2000.

Y. Lee, S. El-andaloussi, and M. J. Wood, Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy, Human Molecular Genetics, vol.21, issue.R1, pp.R125-R134, 2012.

E. Lefrançais, G. Ortiz-muñoz, A. Caudrillier, B. Mallavia, F. Liu et al., The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors, Nature, vol.544, issue.7648, pp.105-109, 2017.

R. L. Levine, M. Wadleigh, J. Cools, B. L. Ebert, G. Wernig et al., Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis, Cancer Cell, vol.7, issue.4, pp.387-397, 2005.

H. D. Lewis, J. Liddle, J. E. Coote, S. J. Atkinson, M. D. Barker et al., Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation, Nature Chemical Biology, vol.11, issue.3, pp.189-191, 2015.

K. Ley, C. Laudanna, M. I. Cybulsky, and S. Nourshargh, Getting to the site of inflammation: the leukocyte adhesion cascade updated, Nature Reviews Immunology, vol.7, issue.9, pp.678-689, 2007.

J. Li, D. G. Kent, A. L. Godfrey, H. Manning, J. Nangalia et al., JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease, Blood, vol.123, issue.20, pp.3139-3151, 2014.

P. Li, M. Li, M. R. Lindberg, M. J. Kennett, N. Xiong et al., PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps, Journal of Experimental Medicine, vol.207, issue.9, pp.1853-1862, 2010.

C. H. Lin, K. Kaushansky, and H. Zhan, JAK2V617F-mutant vascular niche contributes to JAK2V617F clonal expansion in myeloproliferative neoplasms, Blood Cells, Molecules, and Diseases, vol.62, pp.42-48, 2016.

C. H. Lin, Y. Zhang, K. Kaushansky, and H. Zhan, JAK2V617F-bearing vascular niche enhances malignant hematopoietic regeneration following radiation injury, Haematologica, vol.103, issue.7, pp.1160-1168, 2018.

Y. Lin, D. J. Weisdorf, A. Solovey, and R. P. Hebbel, Origins of circulating endothelial cells and endothelial outgrowth from blood, Journal of Clinical Investigation, vol.105, issue.1, pp.71-77, 2000.

K. Lindauer, T. Loerting, K. R. Liedl, and R. T. Kroemer, Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation, Protein Engineering, Design and Selection, vol.14, issue.1, pp.27-37, 2001.

X. Lu, L. Huang, and H. F. Lodish, Dimerization by a Cytokine Receptor Is Necessary for Constitutive Activation of JAK2V617F, Journal of Biological Chemistry, vol.283, issue.9, pp.5258-5266, 2007.

P. Lundberg, A. Karow, R. Nienhold, R. Looser, H. Hao-shen et al., Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms, Blood, vol.123, issue.14, pp.2220-2228, 2014.

F. Lussana, S. Caberlon, C. Pagani, P. W. Kamphuisen, H. R. Büller et al., Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review, Thrombosis Research, vol.124, issue.4, pp.409-417, 2009.

D. Lyden, K. Hattori, S. Dias, C. Costa, P. Blaikie et al., Impaired recruitment of bone-marrow?derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth, Nature Medicine, vol.7, issue.11, pp.1194-1201, 2001.

Y. Maeng, H. Choi, J. Kwon, Y. Park, K. Choi et al., Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLC?2 axis, Blood, vol.113, issue.1, pp.233-243, 2009.

N. Maicas, M. L. Ferrándiz, R. Brines, L. Ibáñez, A. Cuadrado et al., Deficiency of Nrf2 Accelerates the Effector Phase of Arthritis and Aggravates Joint Disease, Antioxidants & Redox Signaling, vol.15, issue.4, pp.889-901, 2011.

N. Malachowa, S. D. Kobayashi, B. Freedman, D. W. Dorward, and F. R. Deleo, Staphylococcus aureusLeukotoxin GH Promotes Formation of Neutrophil Extracellular Traps, The Journal of Immunology, vol.191, issue.12, pp.6022-6029, 2013.

N. Malachowa, S. D. Kobayashi, B. Freedman, D. W. Dorward, and F. R. Deleo, Staphylococcus aureusLeukotoxin GH Promotes Formation of Neutrophil Extracellular Traps, The Journal of Immunology, vol.191, issue.12, pp.6022-6029, 2013.

Z. Mallat, B. Hugel, J. Ohan, G. Lese?che, J. Freyssinet et al., Shed Membrane Microparticles With Procoagulant Potential in Human Atherosclerotic Plaques, Circulation, vol.99, issue.3, pp.348-353, 1999.

Y. Manavski, T. Lucas, S. F. Glaser, L. Dorsheimer, S. Günther et al., Clonal Expansion of Endothelial Cells Contributes to Ischemia-Induced Neovascularization, Circulation Research, vol.122, issue.5, pp.670-677, 2018.

M. Marchetti, E. Castoldi, H. M. Spronk, R. Van-oerle, D. Balducci et al., Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera, Blood, vol.112, issue.10, pp.4061-4068, 2008.

M. Marchetti, C. J. Tartari, L. Russo, M. Panova-noeva, A. Leuzzi et al., Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia, American Journal of Hematology, vol.89, issue.1, pp.68-73, 2013.

R. Marchioli, G. Finazzi, G. Specchia, R. Cacciola, R. Cavazzina et al., Cardiovascular Events and Intensity of Treatment in Polycythemia Vera, New England Journal of Medicine, vol.368, issue.1, pp.22-33, 2013.

F. O. Martinez, A. Sica, A. Mantovani, and M. Locati, Macrophage activation and polarization, Frontiers in Bioscience, vol.13, issue.13, p.453, 2008.

K. Martinod, M. Demers, T. A. Fuchs, S. L. Wong, A. Brill et al., Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice, Proceedings of the National Academy of Sciences, vol.110, issue.21, pp.8674-8679, 2013.

K. Martinod, T. A. Fuchs, N. L. Zitomersky, S. L. Wong, M. Demers et al., PAD4-deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shock, Blood, vol.125, issue.12, pp.1948-1956, 2015.

K. Martinod, T. Witsch, K. Farley, M. Gallant, E. Remold-o'donnell et al., Neutrophil elastase-deficient mice form neutrophil extracellular traps in an experimental model of deep vein thrombosis, Journal of Thrombosis and Haemostasis, vol.14, issue.3, pp.551-558, 2016.

C. Marty, C. Lacout, A. Martin, S. Hasan, S. Jacquot et al., Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice, Blood, vol.116, issue.5, pp.783-787, 2010.

C. Marty, C. Lacout, N. Droin, J. Le-couédic, V. Ribrag et al., A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression, Leukemia, vol.27, issue.11, pp.2187-2195, 2013.

C. Marty, C. Pecquet, H. Nivarthi, M. El-khoury, I. Chachoua et al., Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis, Blood, vol.127, issue.10, pp.1317-1324, 2016.

S. Massberg, L. Grahl, M. Von-bruehl, D. Manukyan, S. Pfeiler et al., Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases, Nature Medicine, vol.16, issue.8, pp.887-896, 2010.

N. Maugeri, M. Brambilla, M. Camera, A. Carbone, E. Tremoli et al., Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation1, Journal of Thrombosis and Haemostasis, vol.4, issue.6, pp.1323-1330, 2006.

L. Mauracher, F. Posch, K. Martinod, E. Grilz, T. Däullary et al., Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients, Journal of Thrombosis and Haemostasis, vol.16, issue.3, pp.508-518, 2018.

M. G. Mazzucconi, R. Redi, S. Bernasconi, L. Bizzoni, F. Dragoni et al., A long-term study of young patients with essential thrombocythemia treated with anagrelide, Haematologica, vol.8, 2004.

S. S. Mccachren, J. Diggs, J. B. Weinberg, and W. A. Dittman, Thrombomodulin expression by human blood monocytes and by human synovial tissue lining macrophages, Blood, vol.78, issue.12, pp.3128-3132, 1991.

M. P. Mcgee, S. Foster, and X. Wang, Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation., Journal of Experimental Medicine, vol.179, issue.6, pp.1847-1854, 1994.

D. J. Mcilroy, A. G. Jarnicki, G. G. Au, N. Lott, D. W. Smith et al., Mitochondrial DNA neutrophil extracellular traps are formed after trauma and subsequent surgery, Journal of Critical Care, vol.29, issue.6, pp.1133.e1-1133.e5, 2014.

A. Medvinsky and E. Dzierzak, Definitive Hematopoiesis Is Autonomously Initiated by the AGM Region, Cell, vol.86, issue.6, pp.897-906, 1996.

R. T. Megens, S. Vijayan, D. Lievens, Y. Döring, M. A. Van-zandvoort et al., Presence of luminal neutrophil extracellular traps in atherosclerosis, Thrombosis and Haemostasis, vol.107, issue.03, pp.597-598, 2012.

J. M. Melero-martin, Z. A. Khan, A. Picard, X. Wu, S. Paruchuri et al., In vivo vasculogenic potential of human blood-derived endothelial progenitor cells, Blood, vol.109, issue.11, pp.4761-4768, 2007.

J. M. Melero-martin, M. E. De-obaldia, S. Kang, Z. A. Khan, L. Yuan et al., Engineering Robust and Functional Vascular Networks In Vivo With Human Adult and Cord Blood?Derived Progenitor Cells, Circulation Research, vol.103, issue.2, pp.194-202, 2008.

H. Meng, S. Yalavarthi, Y. Kanthi, L. F. Mazza, M. A. Elfline et al., In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis, Arthritis & Rheumatology, vol.69, issue.3, pp.655-667, 2017.

M. Messinezy, T. C. Pearson, A. Prochazka, and G. Wetherley-mein, Treatment of primary proliferative polycythaemia by venesection and low dose busulphan: retrospective study from one centre, British Journal of Haematology, vol.61, issue.4, pp.657-666, 1985.

K. D. Metzler, T. A. Fuchs, W. M. Nauseef, D. Reumaux, J. Roesler et al., Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity, Blood, vol.117, issue.3, pp.953-959, 2011.

K. D. Metzler, C. Goosmann, A. Lubojemska, A. Zychlinsky, and V. Papayannopoulos, A Myeloperoxidase-Containing Complex Regulates Neutrophil Elastase Release and Actin Dynamics during NETosis, Cell Reports, vol.8, issue.3, pp.883-896, 2014.

K. D. Metzler, C. Goosmann, A. Lubojemska, A. Zychlinsky, and V. Papayannopoulos, A Myeloperoxidase-Containing Complex Regulates Neutrophil Elastase Release and Actin Dynamics during NETosis, Cell Reports, vol.8, issue.3, pp.883-896, 2014.

A. Michels, L. L. Swystun, S. Albánez, J. Mewburn, K. Sponagle et al., Histones Induce Endothelial Von Willebrand Factor Release and Subsequent Platelet Capture in In Vitro and In Vivo Models, Blood, vol.124, issue.21, pp.2768-2768, 2014.

A. Michels, L. L. Swystun, S. Albánez, J. Mewburn, K. Sponagle et al., Histones Induce Endothelial Von Willebrand Factor Release and Subsequent Platelet Capture in In Vitro and In Vivo Models, Blood, vol.124, issue.21, pp.2768-2768, 2014.

K. Misawa, H. Yasuda, M. Araki, T. Ochiai, S. Morishita et al., The 2016 WHO diagnostic criteria for polycythemia vera renders an accurate diagnosis to a broader range of patients including masked polycythemia vera: Comparison with the 2008 WHO diagnostic criteria, American Journal of Hematology, vol.92, issue.7, pp.E128-E130, 2017.

I. Mitroulis, K. Kambas, A. Chrysanthopoulou, P. Skendros, E. Apostolidou et al., Neutrophil Extracellular Trap Formation Is Associated with IL-1? and Autophagy-Related Signaling in Gout, PLoS ONE, vol.6, issue.12, p.e29318, 2011.

M. Montanaro, R. Latagliata, M. Cedrone, A. Spadea, A. Rago et al., Thrombosis and survival in essential thrombocythemia: A regional study of 1,144 patients, American Journal of Hematology, vol.89, issue.5, pp.542-546, 2014.

M. L. Van-montfoort, F. Stephan, M. N. Lauw, B. A. Hutten, G. J. Van-mierlo et al., Circulating Nucleosomes and Neutrophil Activation as Risk Factors for Deep Vein Thrombosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.33, issue.1, pp.147-151, 2013.

C. Moosbauer, E. Morgenstern, S. L. Cuvelier, D. Manukyan, K. Bidzhekov et al., Eosinophils are a major intravascular location for tissue factor storage and exposure, Blood, vol.109, issue.3, pp.995-1002, 2006.

M. Morshed, R. Hlushchuk, D. Simon, A. F. Walls, K. Obata-ninomiya et al., NADPH Oxidase?Independent Formation of Extracellular DNA Traps by Basophils, The Journal of Immunology, vol.192, issue.11, pp.5314-5323, 2014.

T. Murohara, H. Ikeda, J. Duan, S. Shintani, K. Sasaki et al., Transplanted cord blood?derived endothelial precursor cells augment postnatal neovascularization, Journal of Clinical Investigation, vol.105, issue.11, pp.1527-1536, 2000.

M. D. Muzumdar, B. Tasic, K. Miyamichi, L. Li, and L. Luo, A global double-fluorescent Cre reporter mouse, genesis, vol.45, issue.9, pp.593-605, 2007.

D. D. Myers, J. E. Rectenwald, P. W. Bedard, N. Kaila, G. D. Shaw et al., Decreased venous thrombosis with an oral inhibitor of P selectin, Journal of Vascular Surgery, vol.42, issue.2, pp.329-336, 2005.

B. M. Nadin, M. A. Goodell, and K. K. Hirschi, Phenotype and hematopoietic potential of side population cells throughout embryonic development, Blood, vol.102, issue.7, pp.2436-2443, 2003.

Y. Nadir, B. Brenner, A. Zetser, N. Ilan, I. Shafat et al., Heparanase induces tissue factor expression in vascular endothelial and cancer cells, Journal of Thrombosis and Haemostasis, vol.4, issue.11, pp.2443-2451, 2006.

Y. Nadir, B. Brenner, S. Gingis-velitski, F. Levy-adam, N. Ilan et al., Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells, Thrombosis and Haemostasis, vol.99, issue.01, pp.133-141, 2008.

Y. Nadir, B. Brenner, L. Fux, I. Shafat, J. Attias et al., Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII, Haematologica, vol.95, issue.11, pp.1927-1934, 2010.

H. Naito, H. Kidoya, S. Sakimoto, T. Wakabayashi, and N. Takakura, Identification and characterization of a resident vascular stem/progenitor cell population in preexisting blood vessels, The EMBO Journal, vol.31, issue.4, pp.842-855, 2011.

Y. Najean and J. Rain, Treatment of Polycythemia Vera: The Use of Hydroxyurea and Pipobroman in 292 Patients Under the Age of 65 Years, Blood, vol.90, issue.9, pp.3370-3377, 1997.

S. Nakamura, T. Imamura, and K. Okamoto, Tissue factor in neutrophils: yes, Journal of Thrombosis and Haemostasis, vol.2, issue.2, pp.214-217, 2004.

J. Nangalia, C. E. Massie, E. J. Baxter, F. L. Nice, G. Gundem et al., Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2, vol.369, pp.2391-2405, 2013.

M. Napirei, S. Ludwig, J. Mezrhab, T. Klöckl, and H. G. Mannherz, Murine serum nucleases - contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3), FEBS Journal, vol.276, issue.4, pp.1059-1073, 2009.

M. E. Nesheim, J. B. Taswell, and K. G. Mann, The contribution of bovine Factor V and Factor Va to the activity of prothrombinase, J. Biol. Chem, vol.254, pp.10952-10962, 1979.

H. Nivarthi, D. Chen, C. Cleary, B. Kubesova, R. Jäger et al., Thrombopoietin receptor is required for the oncogenic function of CALR mutants, Leukemia, vol.30, issue.8, pp.1759-1763, 2016.

E. Oppliger-leibundgut, M. P. Horn, C. Brunold, B. Pfanner-meyer, D. Marti et al., Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases, Haematologica, vol.8, 2006.

T. Orfeo, N. Brufatto, M. E. Nesheim, H. Xu, S. Butenas et al., The Factor V Activation Paradox, Journal of Biological Chemistry, vol.279, issue.19, pp.19580-19591, 2004.

D. Orlic, J. Kajstura, S. Chimenti, F. Limana, I. Jakoniuk et al., Mobilized bone marrow cells repair the infarcted heart, improving function and survival, Proceedings of the National Academy of Sciences, vol.98, issue.18, pp.10344-10349, 2001.

C. P. Oyarzún, A. Carestia, P. R. Lev, A. C. Glembotsky, M. A. Castro-ríos et al., Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms, 2016.

F. Palandri, L. Catani, N. Testoni, E. Ottaviani, N. Polverelli et al., Long-term follow-up of 386 consecutive patients with essential thrombocythemia: Safety of cytoreductive therapy, American Journal of Hematology, vol.84, issue.4, pp.215-220, 2009.

F. Palandri, N. Polverelli, L. Catani, E. Ottaviani, M. Baccarani et al., Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study, Annals of Hematology, vol.90, issue.8, pp.933-938, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00615421

F. Palandri, R. Latagliata, N. Polverelli, A. Tieghi, M. Crugnola et al., Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis, Leukemia, vol.29, issue.6, pp.1344-1349, 2015.

M. Panova-noeva, M. Marchetti, H. M. Spronk, L. Russo, E. Diani et al., Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera, American Journal of Hematology, vol.86, issue.4, pp.337-342, 2011.

M. Panova-noeva, M. Marchetti, S. Buoro, L. Russo, A. Leuzzi et al., JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients, Blood, vol.118, issue.9, pp.2599-2601, 2011.

V. Papayannopoulos, K. D. Metzler, A. Hakkim, and A. Zychlinsky, Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps, Journal of Cell Biology, vol.191, issue.3, pp.677-691, 2010.

A. D. Pardanani, R. L. Levine, T. Lasho, Y. Pikman, R. A. Mesa et al., MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients, Blood, vol.108, issue.10, pp.3472-3476, 2006.

A. D. Pardanani, R. L. Levine, T. Lasho, Y. Pikman, R. A. Mesa et al., MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients, Blood, vol.108, issue.10, pp.3472-3476, 2006.

F. I. Pareti, L. Gugliotta, L. Mannucci, A. Guarini, and P. M. Mannucci, Biochemical and Metabolic Aspects of Platelet Dysfunction in Chronic Myeloproliferative Disorders, Thrombosis and Haemostasis, vol.47, issue.02, pp.084-089, 1982.

S. Pascale, G. Petrucci, A. Dragani, A. Habib, F. Zaccardi et al., Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target, Blood, vol.119, issue.15, pp.3595-3603, 2012.

F. Passamonti, E. Rumi, L. Arcaini, E. Boveri, C. Elena et al., Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients, Haematologica, vol.93, issue.11, pp.1645-1651, 2008.

F. Passamonti, E. Rumi, C. Pascutto, M. Cazzola, and M. Lazzarino, Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia, Journal of Thrombosis and Haemostasis, vol.7, issue.9, pp.1587-1589, 2009.

F. Passamonti, E. Rumi, D. Pietra, C. Elena, E. Boveri et al., A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications, Leukemia, vol.24, issue.9, pp.1574-1579, 2010.

F. Passamonti, C. Elena, S. Schnittger, R. C. Skoda, A. R. Green et al., Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations, Blood, vol.117, issue.10, pp.2813-2816, 2011.

F. Passamonti, M. Griesshammer, F. Palandri, M. Egyed, G. Benevolo et al., Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study, The Lancet Oncology, vol.18, issue.1, pp.88-99, 2017.

S. M. Passamonti, E. Biguzzi, M. Cazzola, F. Franchi, F. Gianniello et al., The JAK2 V617F mutation in patients with cerebral venous thrombosis, Journal of Thrombosis and Haemostasis, vol.10, issue.6, pp.998-1003, 2012.

E. Passegué, E. F. Wagner, and I. L. Weissman, JunB Deficiency Leads to a Myeloproliferative Disorder Arising from Hematopoietic Stem Cells, Cell, vol.119, issue.3, pp.431-443, 2004.

C. Patrono, B. Rocca, and V. De-stefano, Platelet activation and inhibition in polycythemia vera and essential thrombocythemia, Blood, vol.121, issue.10, pp.1701-1711, 2013.

T. Pearson, Hemorheologic Considerations in the Pathogenesis of Vascular Occlusive Events in Polycythemia Vera, Seminars in Thrombosis and Hemostasis, vol.23, issue.05, pp.433-439, 1997.

T. C. Pearson and G. Wetherley-mein, VASCULAR OCCLUSIVE EPISODES AND VENOUS HÆMATOCRIT IN PRIMARY PROLIFERATIVE POLYCYTHÆMLX, The Lancet, vol.312, issue.8102, pp.1219-1222, 1978.

M. Peichev, A. J. Naiyer, D. Pereira, Z. Zhu, W. J. Lane et al., Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors, Blood, vol.95, issue.3, pp.952-958, 2000.

A. Peled, V. Grabovsky, L. Habler, J. Sandbank, F. Arenzana-seisdedos et al., The chemokine SDF-1 stimulates integrin-mediated arrest of CD34+ cells on vascular endothelium under shear flow, Journal of Clinical Investigation, vol.104, issue.9, pp.1199-1211, 1999.

E. Pelosi, M. Valtieri, S. Coppola, R. Botta, M. Gabbianelli et al., Identification of the hemangioblast in postnatal life, Blood, vol.100, issue.9, pp.3203-3208, 2002.

R. Pendu, V. Terraube, O. D. Christophe, C. G. Gahmberg, P. G. De-groot et al., P-selectin glycoprotein ligand 1 and ?2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor, Blood, vol.108, issue.12, pp.3746-3752, 2006.

G. Piaggio, V. Rosti, M. Corselli, F. Bertolotti, G. Bergamaschi et al., Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker, Blood, vol.114, issue.14, pp.3127-3130, 2009.

A. Piccin, M. Steurer, C. Feistritzer, C. Murphy, E. Eakins et al., Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia, Translational Research, vol.184, pp.21-34, 2017.

A. Pich, L. Riera, E. Beggiato, B. Nicolino, L. Godio et al., JAK2V617F mutation and allele burden are associated with distinct clinical and morphological subtypes in patients with essential thrombocythaemia, Journal of Clinical Pathology, vol.65, issue.10, pp.953-955, 2012.

Y. Pikman, B. H. Lee, T. Mercher, E. Mcdowell, B. L. Ebert et al., MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia, PLoS Medicine, vol.3, issue.7, p.e270, 2006.

K. Pillarisetti and S. K. Gupta, Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction, Inflammation, vol.25, pp.293-300, 2001.

F. H. Pilsczek, D. Salina, K. K. Poon, C. Fahey, B. G. Yipp et al., A Novel Mechanism of Rapid Nuclear Neutrophil Extracellular Trap Formation in Response toStaphylococcus aureus, The Journal of Immunology, vol.185, issue.12, pp.7413-7425, 2010.

D. J. Pinsky, Y. Naka, H. Liao, M. C. Oz, D. D. Wagner et al., Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation., Journal of Clinical Investigation, vol.97, issue.2, pp.493-500, 1996.

J. Plescia and D. C. Altieri, Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation, Biochemical Journal, vol.319, issue.3, pp.873-879, 1996.

J. Poisson, A. Plessier, J. Kiladjian, F. Turon, B. Cassinat et al., Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study, Journal of Hepatology, vol.67, issue.3, pp.501-507, 2017.

. Policitemia, Low-dose aspirin in polycythaemia vera: a pilot study, Br. J. Haematol, vol.97, pp.453-456, 1997.

F. E. Preston, I. G. Emmanuel, D. A. Winfield, and R. G. Malia, Essential Thrombocythaemia and Peripheral Gangrene, BMJ, vol.3, issue.5930, pp.548-552, 1974.

M. H. Prins, A. W. Lensing, T. A. Brighton, R. M. Lyons, J. Rehm et al., Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials, The Lancet Haematology, vol.1, issue.1, pp.e37-e46, 2014.

A. Quintás-cardama, O. Abdel-wahab, T. Manshouri, O. Kilpivaara, J. Cortes et al., Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon ?-2a, Blood, vol.122, issue.6, pp.893-901, 2013.

G. E. Raskob, N. Van-es, P. Verhamme, M. Carrier, M. Di-nisio et al., Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism, New England Journal of Medicine, vol.378, issue.7, pp.615-624, 2018.

A. Regev, P. Stark, D. Blickstein, and M. Lahav, Thrombotic complications in essential thrombocythemia with relatively low platelet counts, American Journal of Hematology, vol.56, issue.3, pp.168-172, 1997.

G. M. Rigolin, C. Fraulini, M. Ciccone, E. Mauro, A. M. Bugli et al., Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion, Blood, vol.107, issue.6, pp.2531-2535, 2006.

N. C. Rochael, A. B. Guimarães-costa, M. T. Nascimento, T. S. Desouza-vieira, M. P. Oliveira et al., Classical ROS-dependent and early/rapid ROS-independent release of Neutrophil Extracellular Traps triggered by Leishmania parasites, Scientific Reports, vol.5, issue.1, 2015.

J. Rossaint, J. M. Herter, H. Van-aken, M. Napirei, Y. Döring et al., Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap?mediated sterile inflammation, Blood, vol.123, issue.16, pp.2573-2584, 2014.

L. Rössig, C. Urbich, T. Brühl, E. Dernbach, C. Heeschen et al., Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells, J. Exp. Med, vol.201, pp.1825-1835, 2005.

V. Rosti, L. Villani, R. Riboni, V. Poletto, E. Bonetti et al., Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation, Blood, vol.121, issue.2, pp.360-368, 2013.

G. Rotunno, C. Mannarelli, P. Guglielmelli, A. Pacilli, A. Pancrazzi et al., Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia, Blood, vol.123, issue.10, pp.1552-1555, 2014.

E. Rumi, D. Pietra, V. Ferretti, T. Klampfl, A. S. Harutyunyan et al., JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes, Blood, vol.123, issue.10, pp.1544-1551, 2014.

N. H. Russell, J. Salmon, J. P. Keenan, and A. J. Bellingham, Platelet adenine nucleotides and arachidonic acid metabolism in the myeloproliferative disorders, Thrombosis Research, vol.22, issue.4, pp.389-397, 1981.

F. R. Sabin, Preliminary Note on the Differentiation of Angioblasts and the Method by Which They Produce Blood-Vessels, Blood-Plasma and Red Blood-Cells As Seen in the Living Chick, Journal of Hematotherapy & Stem Cell Research, vol.11, issue.1, pp.5-7, 2002.

S. A. Gibson, G. Gao, K. Mcdonagh, and S. Shen, Progress on stem cell research towards the treatment of Parkinson's disease, Stem Cell Research & Therapy, vol.3, issue.2, p.11, 2012.

V. M. Sandler, R. Lis, Y. Liu, A. Kedem, D. James et al., Reprogramming human endothelial cells to haematopoietic cells requires vascular induction, Nature, vol.511, issue.7509, pp.312-318, 2014.

F. Santilli, M. Romano, A. Recchiuti, A. Dragani, A. Falco et al., Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients, Blood, vol.112, issue.4, pp.1085-1090, 2008.

A. Sanz, D. Ungureanu, T. Pekkala, R. Ruijtenbeek, I. P. Touw et al., Analysis of Jak2 Catalytic Function by Peptide Microarrays: The Role of the JH2 Domain and V617F Mutation, PLoS ONE, vol.6, issue.4, p.e18522, 2011.

A. S. Savchenko, K. Martinod, M. A. Seidman, S. L. Wong, J. I. Borissoff et al., Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development, Journal of Thrombosis and Haemostasis, vol.12, issue.6, pp.860-870, 2014.

A. S. Savchenko, J. I. Borissoff, K. Martinod, S. F. De-meyer, M. Gallant et al., VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice, Blood, vol.123, issue.1, pp.141-148, 2014.

A. I. Schafer, Bleeding and thrombosis in the myeloproliferative disorders, Blood, vol.64, issue.1, pp.1-12, 1984.

R. J. Scheubel, H. Zorn, R. Silber, O. Kuss, H. Morawietz et al., Age-dependent depression in circulating endothelial progenitor cells inpatients undergoing coronary artery bypass grafting, Journal of the American College of Cardiology, vol.42, issue.12, pp.2073-2080, 2003.

R. J. Scheubel, H. Zorn, R. Silber, O. Kuss, H. Morawietz et al., Age-dependent depression in circulating endothelial progenitor cells inpatients undergoing coronary artery bypass grafting, Journal of the American College of Cardiology, vol.42, issue.12, pp.2073-2080, 2003.

S. M. Schwartz and E. P. Benditt, Clustering of replicating cells in aortic endothelium., Proceedings of the National Academy of Sciences, vol.73, issue.2, pp.651-653, 1976.

L. M. Scott, The JAK2 exon 12 mutations: A comprehensive review, American Journal of Hematology, vol.86, issue.8, pp.668-676, 2011.

L. M. Scott, M. A. Scott, P. J. Campbell, and A. R. Green, Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia, Blood, vol.108, issue.7, pp.2435-2437, 2006.

L. M. Scott, W. Tong, R. L. Levine, M. A. Scott, P. A. Beer et al., JAK2Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis, New England Journal of Medicine, vol.356, issue.5, pp.459-468, 2007.

M. Sekhar, K. Mcvinnie, and A. K. Burroughs, Splanchnic vein thrombosis in myeloproliferative neoplasms, British Journal of Haematology, vol.162, issue.6, pp.730-747, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02971445

M. Sekhar, D. Patch, B. Austen, J. Howard, and S. Hart, Calreticulin mutations and their importance in splanchnic vein thrombosis, British Journal of Haematology, vol.174, issue.1, pp.158-160, 2015.

F. Semeraro, C. T. Ammollo, J. H. Morrissey, G. L. Dale, P. Friese et al., Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4, Blood, vol.118, issue.7, pp.1952-1961, 2011.

E. Shantsila and G. Y. Lip, The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms, Thromb. Haemost, vol.102, pp.916-924, 2009.

S. Shintani, T. Murohara, H. Ikeda, T. Ueno, T. Honma et al., Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction, Circulation, vol.103, issue.23, pp.2776-2779, 2001.

R. T. Silver, K. Vandris, Y. L. Wang, F. Adriano, A. V. Jones et al., JAK2V617F allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy, Leukemia Research, vol.35, issue.2, pp.177-182, 2011.

I. Slaba, J. Wang, E. Kolaczkowska, B. Mcdonald, W. Lee et al., Imaging the dynamic platelet-neutrophil response in sterile liver injury and repair in mice, Hepatology, vol.62, issue.5, pp.1593-1605, 2015.

J. H. Smalberg, L. R. Arends, D. C. Valla, J. Kiladjian, H. L. Janssen et al., Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis, Blood, vol.120, issue.25, pp.4921-4928, 2012.

S. Sozer, M. I. Fiel, T. Schiano, M. Xu, J. Mascarenhas et al., The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome, Blood, vol.113, issue.21, pp.5246-5249, 2009.

S. Sozer, T. Ishii, M. I. Fiel, J. Wang, X. Wang et al., Human CD34+ cells are capable of generating normal and JAK2V617F positive endothelial like cells in vivo, Blood Cells, Molecules, and Diseases, vol.43, issue.3, pp.304-312, 2009.

D. A. Stakos, K. Kambas, T. Konstantinidis, I. Mitroulis, E. Apostolidou et al., Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction, European Heart Journal, vol.36, issue.22, pp.1405-1414, 2015.

V. De-stefano, A. Fiorini, E. Rossi, T. Za, G. Farina et al., Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders, Journal of Thrombosis and Haemostasis, vol.5, issue.4, pp.708-714, 2007.

E. C. Storen and A. Tefferi, Long-term use of anagrelide in young patients with essential thrombocythemia, Blood, vol.97, issue.4, pp.863-866, 2001.

C. Strassel, L. Kubovcakova, P. H. Mangin, C. Ravanat, M. Freund et al., Haemorrhagic and thrombotic diatheses in mouse models with thrombocytosis, Thrombosis and Haemostasis, vol.113, issue.02, pp.414-425, 2015.

B. Streubel, M. Exner, I. ;. Schwarzinger, A. M. Vannucchi, and T. Barbui, Lymphoma-Specific Genetic Aberrations Tefferi, A, Blood Cancer J, vol.8, 2004.

L. Teofili, M. Martini, M. G. Iachininoto, S. Capodimonti, E. R. Nuzzolo et al., Endothelial progenitor cells are clonal and exhibit the JAK2V617F mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms, Blood, vol.117, issue.9, pp.2700-2707, 2011.

C. Thålin, M. Demers, B. Blomgren, S. L. Wong, M. Von-arbin et al., NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation, Thrombosis Research, vol.139, pp.56-64, 2016.

R. Tiedt, T. Schomber, H. Hao-shen, and R. C. Skoda, Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo, Blood, vol.109, issue.4, pp.1503-1506, 2006.

R. Tiedt, H. Hao-shen, M. A. Sobas, R. Looser, S. Dirnhofer et al., Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice, Blood, vol.111, issue.8, pp.3931-3940, 2008.

L. J. Toltl, S. Beaudin, and P. C. Liaw, Activated Protein C Up-Regulates IL-10 and Inhibits Tissue Factor in Blood Monocytes, The Journal of Immunology, vol.181, issue.3, pp.2165-2173, 2008.

D. Tong, M. Yu, L. Guo, T. Li, J. Li et al., Phosphatidylserine-exposing blood and endothelial cells contribute to the hypercoagulable state in essential thrombocythemia patients, Annals of Hematology, vol.97, issue.4, pp.605-616, 2018.

C. Torres, A. M. Fonseca, M. Leander, R. Matos, S. Morais et al., Circulating Endothelial Cells in Patients with Venous Thromboembolism and Myeloproliferative Neoplasms, PLoS ONE, vol.8, issue.12, p.e81574, 2013.

M. Trappenburg, M. Van-schilfgaarde, M. Marchetti, H. Spronk, H. Ten-cate et al., Elevated Procoagulant Microparticles Expressing Endothelial and Platelet Markers in Essential Thrombocythemia, Blood, vol.112, issue.11, pp.2793-2793, 2008.

J. Treli?ski, A. Wierzbowska, A. Krawczy?ska, A. Sakowicz, T. Pietrucha et al., Plasma levels of angiogenic factors and circulating endothelial cells in essential thrombocythemia: correlation with cytoreductive therapy andJAK2?V617Fmutational status, Leukemia & Lymphoma, vol.51, issue.9, pp.1-7, 2010.

O. Tura, J. Crawford, G. R. Barclay, K. Samuel, P. W. Hadoke et al., Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy, Journal of Thrombosis and Haemostasis, vol.8, issue.7, pp.1614-1623, 2010.

V. Turitto and H. Weiss, Red blood cells: their dual role in thrombus formation, Science, vol.207, issue.4430, pp.541-543, 1980.

V. T. Turitto and H. J. Weiss, PLATELET AND RED CELL INVOLVEMENT IN MURAL THROMBOGENESIS, Annals of the New York Academy of Sciences, vol.416, issue.1 Surface Pheno, pp.363-376, 1983.

F. Turon, F. Cervantes, D. Colomer, A. Baiges, V. Hernández-gea et al., Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis, Journal of Hepatology, vol.62, issue.1, pp.72-74, 2015.

S. Ueki, R. C. Melo, I. Ghiran, L. A. Spencer, A. M. Dvorak et al., Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans, Blood, vol.121, issue.11, pp.2074-2083, 2013.

S. Ueki, R. C. Melo, I. Ghiran, L. A. Spencer, A. M. Dvorak et al., Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans, Blood, vol.121, issue.11, pp.2074-2083, 2013.

S. Ueki, Y. Konno, M. Takeda, Y. Moritoki, M. Hirokawa et al., Eosinophil extracellular trap cell death?derived DNA traps: Their presence in secretions and functional attributes, Journal of Allergy and Clinical Immunology, vol.137, issue.1, pp.258-267, 2016.

P. Vajkoczy, S. Blum, M. Lamparter, R. Mailhammer, R. Erber et al., Multistep Nature of Microvascular Recruitment of Ex Vivo?expanded Embryonic Endothelial Progenitor Cells during Tumor Angiogenesis, Journal of Experimental Medicine, vol.197, issue.12, pp.1755-1765, 2003.

D. R. Vandevanter, M. L. Craib, D. J. Pasta, S. J. Millar, W. J. Morgan et al., Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen change, Pediatric Pulmonology, vol.53, issue.1, pp.43-49, 2017.

A. M. Vannucchi, E. Antonioli, P. Guglielmelli, G. Longo, A. Pancrazzi et al., Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden, Leukemia, vol.21, issue.9, pp.1952-1959, 2007.

A. M. Vannucchi, E. Antonioli, P. Guglielmelli, A. Pancrazzi, V. Guerini et al., Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia, Blood, vol.112, issue.3, pp.844-847, 2008.

A. M. Vannucchi, J. J. Kiladjian, M. Griesshammer, T. Masszi, S. Durrant et al., Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera, New England Journal of Medicine, vol.372, issue.5, pp.426-435, 2015.

A. M. Vannucchi, S. Verstovsek, P. Guglielmelli, M. Griesshammer, T. C. Burn et al., Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study, Annals of Hematology, vol.96, issue.7, pp.1113-1120, 2017.

J. W. Vardiman, J. Thiele, D. A. Arber, R. D. Brunning, M. J. Borowitz et al., The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes, Blood, vol.114, issue.5, pp.937-951, 2009.

M. C. Vedovati, F. Germini, G. Agnelli, and C. Becattini, Direct Oral Anticoagulants in Patients With VTE and Cancer, Chest, vol.147, issue.2, pp.475-483, 2015.

E. Verger, B. Cassinat, A. Chauveau, C. Dosquet, S. Giraudier et al., Clinical and molecular response to interferon-? therapy in essential thrombocythemia patients with CALR mutations, Blood, vol.126, issue.24, pp.2585-2591, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01276534

S. Verstovsek, A. M. Vannucchi, M. Griesshammer, T. Masszi, S. Durrant et al., Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial, Haematologica, vol.101, issue.7, pp.821-829, 2016.

U. M. Vischer and C. B. Wollheinn, Epinephrine Induces von Willebrand Factor Release from Cultured Endothelial Cells: Involvement of Cyclic AMP-dependent Signalling in Exocytosis, Thrombosis and Haemostasis, vol.77, issue.06, pp.1182-1188, 1997.

J. Vreeken and W. G. Van-aken, SPONTANEOUS AGGREGATION OF BLOOD PLATELETS AS A CAUSE OF IDIOPATHIC THROMBOSIS AND RECURRENT PAINFUL TOES AND FINGERS, The Lancet, vol.298, issue.7739, pp.1394-1397, 1971.

T. W. Wakefield, D. D. Myers, and P. K. Henke, Mechanisms of Venous Thrombosis and Resolution, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, issue.3, pp.387-391, 2008.

J. Wang and P. Kubes, A Reservoir of Mature Cavity Macrophages that Can Rapidly Invade Visceral Organs to Affect Tissue Repair, Cell, vol.165, issue.3, pp.668-678, 2016.

S. Wang and Y. Wang, Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol.1829, issue.10, pp.1126-1135, 2013.

A. Warnatsch, M. Ioannou, Q. Wang, and V. Papayannopoulos, Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis, Science, vol.349, issue.6245, pp.316-320, 2015.

M. Wautier, W. El-nemer, P. Gane, J. Rain, J. Cartron et al., Increased adhesion to endothelial cells of erythrocytes from patients with polycythemia vera is mediated by laminin ?5 chain and Lu/BCAM, Blood, vol.110, issue.3, pp.894-901, 2007.

E. S. Wijelath, S. Rahman, J. Murray, Y. Patel, G. Savidge et al., Fibronectin promotes VEGF-induced CD34+ cell differentiation into endothelial cells, Journal of Vascular Surgery, vol.39, issue.3, pp.655-660, 2004.

E. S. Wijelath, S. Rahman, J. Murray, Y. Patel, G. Savidge et al., Fibronectin promotes VEGF-induced CD34+ cell differentiation into endothelial cells, Journal of Vascular Surgery, vol.39, issue.3, pp.655-660, 2004.

V. C. Willis, A. M. Gizinski, N. K. Banda, C. P. Causey, B. Knuckley et al., N-?-Benzoyl-N5-(2-Chloro-1-Iminoethyl)-l-Ornithine Amide, a Protein Arginine Deiminase Inhibitor, Reduces the Severity of Murine Collagen-Induced Arthritis, The Journal of Immunology, vol.186, issue.7, pp.4396-4404, 2011.

O. Wolach, R. S. Sellar, K. Martinod, D. Cherpokova, M. Mcconkey et al., Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms, Science Translational Medicine, vol.10, issue.436, p.eaan8292, 2018.

O. Wolach, R. S. Sellar, K. Martinod, D. Cherpokova, M. Mcconkey et al., Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms, Science Translational Medicine, vol.10, issue.436, p.eaan8292, 2018.

O. Wolach, R. S. Sellar, K. Martinod, D. Cherpokova, M. Mcconkey et al., Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms, Science Translational Medicine, vol.10, issue.436, p.eaan8292, 2018.

A. P. Wolanskyj, S. M. Schwager, R. F. Mcclure, D. R. Larson, and A. Tefferi, Essential Thrombocythemia Beyond the First Decade: Life Expectancy, Long-term Complication Rates, and Prognostic Factors, Mayo Clinic Proceedings, vol.81, issue.2, pp.159-166, 2006.

A. P. Wolanskyj, S. M. Schwager, R. F. Mcclure, D. R. Larson, and A. Tefferi, Essential Thrombocythemia Beyond the First Decade: Life Expectancy, Long-term Complication Rates, and Prognostic Factors, Mayo Clinic Proceedings, vol.81, issue.2, pp.159-166, 2006.

S. L. Wong, M. Demers, K. Martinod, M. Gallant, Y. Wang et al., Diabetes primes neutrophils to undergo NETosis, which impairs wound healing, Nature Medicine, vol.21, issue.7, pp.815-819, 2015.

J. Wu, L. Huang, M. Huang, W. Liu, M. Zheng et al., Dominant contribution of malignant endothelial cells to endotheliopoiesis in chronic myeloid leukemia, Experimental Hematology, vol.37, issue.1, pp.87-91, 2009.

X. Wu, M. W. Lensch, J. Wylie-sears, G. Q. Daley, and J. Bischoff, Hemogenic Endothelial Progenitor Cells Isolated from Human Umbilical Cord Blood, Stem Cells, vol.25, issue.11, pp.2770-2776, 2007.

J. Xu, X. Zhang, R. Pelayo, M. Monestier, C. T. Ammollo et al., Extracellular histones are major mediators of death in sepsis, Nature Medicine, vol.15, issue.11, pp.1318-1321, 2009.

S. Yalavarthi, T. J. Gould, A. N. Rao, L. F. Mazza, A. E. Morris et al., Release of Neutrophil Extracellular Traps by Neutrophils Stimulated With Antiphospholipid Antibodies: A Newly Identified Mechanism of Thrombosis in the Antiphospholipid Syndrome, Arthritis & Rheumatology, vol.67, issue.11, pp.2990-3003, 2015.

S. Yan, N. Mackman, W. Kisiel, D. M. Stern, and D. J. Pinsky, Hypoxia/Hypoxemia-Induced Activation of the Procoagulant Pathways and the Pathogenesis of Ischemia-Associated Thrombosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.19, issue.9, pp.2029-2035, 1999.

S. Yan, N. Mackman, W. Kisiel, D. M. Stern, and D. J. Pinsky, Hypoxia/Hypoxemia-Induced Activation of the Procoagulant Pathways and the Pathogenesis of Ischemia-Associated Thrombosis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.19, issue.9, pp.2029-2035, 1999.

X. Yang, L. Li, J. Liu, B. Lv, and F. Chen, Extracellular histones induce tissue factor expression in vascular endothelial cells via TLR and activation of NF-?B and AP-1, Thrombosis Research, vol.137, pp.211-218, 2016.

B. G. Yipp, B. Petri, D. Salina, C. N. Jenne, B. N. Scott et al., Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo, Nature Medicine, vol.18, issue.9, pp.1386-1393, 2012.

M. C. Yoder, Is Endothelium the Origin of Endothelial Progenitor Cells?, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.30, issue.6, pp.1094-1103, 2010.

M. C. Yoder, L. E. Mead, D. Prater, T. R. Krier, K. N. Mroueh et al., Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals, Blood, vol.109, issue.5, pp.1801-1809, 2006.

S. Yousefi, J. A. Gold, N. Andina, J. J. Lee, A. M. Kelly et al., Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense, Nature Medicine, vol.14, issue.9, pp.949-953, 2008.

A. Straumann, J. Reichenbach, and G. J. Gleich, Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense, Nat. Med, vol.14, pp.949-953, 2008.

S. Yousefi, C. Mihalache, E. Kozlowski, I. Schmid, and H. U. Simon, Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps, Cell Death & Differentiation, vol.16, issue.11, pp.1438-1444, 2009.

S. Yousefi, D. Simon, and H. Simon, Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease, Current Opinion in Immunology, vol.24, issue.6, pp.736-739, 2012.

S. Yousefi, M. Morshed, P. Amini, D. Stojkov, D. Simon et al., Basophils exhibit antibacterial activity through extracellular trap formation, Allergy, vol.70, issue.9, pp.1184-1188, 2015.

Q. C. Yu, W. Song, D. Wang, and Y. A. Zeng, Identification of blood vascular endothelial stem cells by the expression of protein C receptor, Cell Research, vol.26, issue.10, pp.1079-1098, 2016.

K. Zabieglo, P. Majewski, M. Majchrzak-gorecka, A. Wlodarczyk, B. Grygier et al., The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps, Journal of Leukocyte Biology, vol.98, issue.1, pp.99-106, 2015.

A. Zarbock, K. Ley, R. P. Mcever, and A. Hidalgo, Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow, Blood, vol.118, issue.26, pp.6743-6751, 2011.

H. Zhan, C. H. Lin, Y. Segal, and K. Kaushansky, The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms, Leukemia, vol.32, issue.2, pp.462-469, 2017.

B. Zhao, G. Keerthivasan, Y. Mei, J. Yang, J. Mcelherne et al., Targeted shRNA screening identified critical roles of pleckstrin-2 in erythropoiesis, Haematologica, vol.99, issue.7, pp.1157-1167, 2014.

B. Zhao, Y. Mei, L. Cao, J. Zhang, R. Sumagin et al., Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms, Journal of Clinical Investigation, vol.128, issue.1, pp.125-140, 2017.

B. Zhao, A. K. Chauhan, M. Canault, I. S. Patten, J. J. Yang et al., von Willebrand factor?cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke, Blood, vol.114, issue.15, pp.3329-3334, 2009.

A. C. Zovein, J. J. Hofmann, M. Lynch, W. J. French, K. A. Turlo et al., Fate Tracing Reveals the Endothelial Origin of Hematopoietic Stem Cells, Cell Stem Cell, vol.3, issue.6, pp.625-636, 2008.